SEC Info - Tian’an Technology Group Ltd. - ‘20-F’ for 12/31/23

SEC Info℠

Home

Help

Please Sign In

Tian’an Technology Group Ltd. – ‘20-F’ for 12/31/23 – ‘XML’

On: Monday, 4/1/24, at 6:16pm ET · As of: 4/2/24 · For: 12/31/23 · Accession #: 1493152-24-12556 · File #: 333-267453

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/02/24  Tian’an Technology Group Ltd.     20-F       12/31/23   68:18M                                    M2 Compliance LLC/FA

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer — Form 20-F — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual or Annual-Transition Report by a Foreign     HTML   1.30M 
                Non-Canadian Issuer                                              
 3: EX-10.10    Material Contract                                   HTML     70K 
 4: EX-10.11    Material Contract                                   HTML     19K 
 2: EX-10.9     Material Contract                                   HTML     70K 
 5: EX-14.1     Code of Ethics                                      HTML     36K 
 6: EX-21.1     Subsidiaries List                                   HTML     18K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
16: R1          Cover                                               HTML     91K 
17: R2          Consolidated Balance Sheets                         HTML     93K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     29K 
19: R4          Consolidated Statements of Operations and           HTML    109K 
                Comprehensive Loss                                               
20: R5          Consolidated Statements of Changes in               HTML     51K 
                Stockholders' Equity                                             
21: R6          Consolidated Statements of Cash Flows               HTML    103K 
22: R7          Nature of Operations and Summary of Significant     HTML     84K 
                Accounting Policies                                              
23: R8          Going Concern                                       HTML     25K 
24: R9          Equipment, Net                                      HTML     24K 
25: R10         Leases                                              HTML     34K 
26: R11         Loan Payables                                       HTML     27K 
27: R12         Related Party Transactions                          HTML     42K 
28: R13         Other Payables                                      HTML     22K 
29: R14         Shares to Be Issued                                 HTML     23K 
30: R15         Equity                                              HTML     30K 
31: R16         Taxes                                               HTML     39K 
32: R17         Net Loss Per Share                                  HTML     29K 
33: R18         Statutory Reserves                                  HTML     25K 
34: R19         Segments                                            HTML     58K 
35: R20         Concentrations of Risk                              HTML     42K 
36: R21         Nature of Operations and Summary of Significant     HTML    108K 
                Accounting Policies (Policies)                                   
37: R22         Nature of Operations and Summary of Significant     HTML     41K 
                Accounting Policies (Tables)                                     
38: R23         Leases (Tables)                                     HTML     33K 
39: R24         Taxes (Tables)                                      HTML     28K 
40: R25         Net Loss Per Share (Tables)                         HTML     27K 
41: R26         Segments (Tables)                                   HTML     53K 
42: R27         Concentrations of Risk (Tables)                     HTML     33K 
43: R28         Schedule of Consolidated Companies (Details)        HTML     36K 
44: R29         Schedule of Translation of Foreign Currencies       HTML     33K 
                (Details)                                                        
45: R30         Nature of Operations and Summary of Significant     HTML     29K 
                Accounting Policies (Details Narrative)                          
46: R31         Going Concern (Details Narrative)                   HTML     32K 
47: R32         Equipment, Net (Details Narrative)                  HTML     29K 
48: R33         Schedule of Lease Cost (Details)                    HTML     27K 
49: R34         Schedule of Supplementary Cash Flow Information     HTML     25K 
                (Details)                                                        
50: R35         Leases (Details Narrative)                          HTML     20K 
51: R36         Loan Payables (Details Narrative)                   HTML     28K 
52: R37         Related Party Transactions (Details Narrative)      HTML     70K 
53: R38         Other Payables (Details Narrative)                  HTML     21K 
54: R39         Shares to Be Issued (Details Narrative)             HTML     32K 
55: R40         Equity (Details Narrative)                          HTML     37K 
56: R41         Schedule of Effective Income Tax Rate               HTML     34K 
                Reconciliation (Details)                                         
57: R42         Taxes (Details Narrative)                           HTML     32K 
58: R43         Schedule of Basic and Diluted Net Loss Per Share    HTML     49K 
                (Details)                                                        
59: R44         Statutory Reserves (Details Narrative)              HTML     22K 
60: R45         Schedule of Reportable Business Segments (Details)  HTML     79K 
61: R46         Segments (Details Narrative)                        HTML     21K 
62: R47         Schedule of Concentration of Risk (Details)         HTML     40K 
63: R48         Concentrations of Risk (Details Narrative)          HTML     20K 
65: XML         IDEA XML File -- Filing Summary                      XML    111K 
68: XML         XBRL Instance -- form20-f_htm                        XML    726K 
64: EXCEL       IDEA Workbook of Financial Report Info              XLSX     92K 
12: EX-101.CAL  XBRL Calculations -- tanaf-20231231_cal              XML    129K 
13: EX-101.DEF  XBRL Definitions -- tanaf-20231231_def               XML    330K 
14: EX-101.LAB  XBRL Labels -- tanaf-20231231_lab                    XML    620K 
15: EX-101.PRE  XBRL Presentations -- tanaf-20231231_pre             XML    471K 
11: EX-101.SCH  XBRL Schema -- tanaf-20231231                        XSD    103K 
66: JSON        XBRL Instance as JSON Data -- MetaLinks              298±   418K 
67: ZIP         XBRL Zipped Folder -- 0001493152-24-012556-xbrl      Zip    929K

‘XML’ — XBRL Instance — form20-f_htm

This Document is an XBRL File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="tanaf-20231231.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis"> dei:BusinessContactMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:NonrelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:NonrelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:RelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:RelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:NonrelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:NonrelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:RelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:RelatedPartyMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> TANAF:TiananTechnologyGroupLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> TANAF:TiananTechnologyGroupLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> TANAF:YunkeJingrongInformationTechnologyCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> TANAF:YunkeJingrongInformationTechnologyCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> TANAF:ShanghaiQuigePowerTechnologyCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> TANAF:ShanghaiQuigePowerTechnologyCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> TANAF:YearEndedRMBUSDExchangeRateMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> TANAF:YearEndedRMBUSDExchangeRateMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> TANAF:AverageYearlyRMBUSDExchangeRateMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> TANAF:AverageYearlyRMBUSDExchangeRateMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> TANAF:LoanAgreementMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> TANAF:ShenzhenShihongEducationAndCultureLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:LiaoningXinjianLinguoYitangHealthManagementLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:LiaoningXinjianLinguoYitangHealthManagementLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:LiaoningXinjianLinguoYitangHealthManagementLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:LiaoningXinjianLinguoYitangHealthManagementLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrHengFeiYangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrHengFeiYangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrHengFeiYangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrHengFeiYangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrHengFeiYangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrJinhuaXuMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrJinhuaXuMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrJinhuaXuMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrJinhuaXuMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MrJinhuaXuMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MsXiaoyanYuanMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MsXiaoyanYuanMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MsXiaoyanYuanMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:MsXiaoyanYuanMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:SuzhouAxixiHealthTechnologyCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:SuzhouAxixiHealthTechnologyCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:ShanghaiShengjiTradingCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:ShanghaiShengjiTradingCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:SuzhouXinjianlinHealthManagementCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:SuzhouXinjianlinHealthManagementCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:SuzhouXinjianlinHealthManagementCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> TANAF:SuzhouXinjianlinHealthManagementCoLtdMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis"> TANAF:MrGangWangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis"> TANAF:MrGangWangMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis"> TANAF:MrLihongZouMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis"> TANAF:MrLihongZouMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</entity>

</period>

</context>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis"> TANAF:SixtySixIndividualMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:HealthCareSegmentMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:HealthCareSegmentMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:MotorControllerMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:MotorControllerMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:HealthCareSegmentMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:HealthCareSegmentMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:MotorControllerMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> TANAF:MotorControllerMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerAMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerAMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerBMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerBMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerCMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerCMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerDMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerDMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerEMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerEMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerFMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:CustomerFMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:SuppliersAAMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:SuppliersAAMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:SuppliersBBMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> TANAF:SuppliersBBMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>

<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>

</segment>

</entity>

</period>

</context>

</unit>

<measure> shares </measure>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

</unit>

</unit>

<measure> TANAF:Segments </measure>

</unit>

<dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003"> false </dei:AmendmentFlag>

<dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-12-31" id="Fact000004"> FY </dei:DocumentFiscalPeriodFocus>

<dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000005"> 0001941189 </dei:EntityCentralIndexKey>

<dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0024"> D8 </dei:EntityIncorporationStateCountryCode>

<us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-12-31" id="xdx2ixbrl0065" unitRef="USD" xsi:nil="true"/>

<us-gaap:AccountsPayableCurrent contextRef="AsOf2023-12-31" id="xdx2ixbrl0082" unitRef="USD" xsi:nil="true"/>

<us-gaap:TaxesPayableCurrent contextRef="AsOf2023-12-31" id="xdx2ixbrl0088" unitRef="USD" xsi:nil="true"/>

<TANAF:SharesToBeIssued contextRef="AsOf2022-12-31" id="xdx2ixbrl0104" unitRef="USD" xsi:nil="true"/>

<us-gaap:CommitmentsAndContingencies contextRef="AsOf2023-12-31" id="xdx2ixbrl0109" unitRef="USD" xsi:nil="true"/>

<us-gaap:CommitmentsAndContingencies contextRef="AsOf2022-12-31" id="xdx2ixbrl0110" unitRef="USD" xsi:nil="true"/>

<us-gaap:CommonStockValue contextRef="AsOf2023-12-31" id="xdx2ixbrl0115" unitRef="USD" xsi:nil="true"/>

<us-gaap:CommonStockValue contextRef="AsOf2022-12-31" id="xdx2ixbrl0116" unitRef="USD" xsi:nil="true"/>

<us-gaap:ResearchAndDevelopmentExpense contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0173" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0203" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0204" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0234" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0235" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0242" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0243" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0245" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0248" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0250" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0251" unitRef="USD" xsi:nil="true"/>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0256" unitRef="USD" xsi:nil="true"/>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0257" unitRef="USD" xsi:nil="true"/>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0258" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0262" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0270" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetIncomeLoss contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0278" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetIncomeLoss contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0279" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetIncomeLoss contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0281" unitRef="USD" xsi:nil="true"/>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0284" unitRef="USD" xsi:nil="true"/>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0285" unitRef="USD" xsi:nil="true"/>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0286" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0290" unitRef="USD" xsi:nil="true"/>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0298" unitRef="USD" xsi:nil="true"/>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0315" unitRef="USD" xsi:nil="true"/>

<us-gaap:GainLossOnDispositionOfAssets1 contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0318" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0322" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncreaseDecreaseInInventories contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0327" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0345" unitRef="USD" xsi:nil="true"/>

<TANAF:ProceedsFromSharesToBeIssued contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0358" unitRef="USD" xsi:nil="true"/>

<us-gaap:ProceedsFromContributedCapital contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0360" unitRef="USD" xsi:nil="true"/>

<us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0369" unitRef="USD" xsi:nil="true"/>

<us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0378" unitRef="USD" xsi:nil="true"/>

<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0381" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxesPaidNet contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0402" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxesPaidNet contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0403" unitRef="USD" xsi:nil="true"/>

<TANAF:EstablishmentOfRightOfUseAssetsAndLeaseLiabilitiesForNewLeases contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0408" unitRef="USD" xsi:nil="true"/>

<TANAF:EstablishmentOfRightOfUseAssetsAndLeaseLiabilitiesForNewLeases contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0409" unitRef="USD" xsi:nil="true"/>

<TANAF:ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0411" unitRef="USD" xsi:nil="true"/>

<us-gaap:OperatingLeaseCost contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0519" unitRef="USD" xsi:nil="true"/>

<us-gaap:VariableLeaseCost contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0525" unitRef="USD" xsi:nil="true"/>

<us-gaap:VariableLeaseCost contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0526" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0533" unitRef="USD" xsi:nil="true"/>

<us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0536" unitRef="USD" xsi:nil="true"/>

<us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0537" unitRef="USD" xsi:nil="true"/>

<TANAF:ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0539" unitRef="USD" xsi:nil="true"/>

<us-gaap:LoansPayable contextRef="AsOf2023-12-31" id="xdx2ixbrl0548" unitRef="USD" xsi:nil="true"/>

<us-gaap:LoansPayable contextRef="AsOf2022-12-31" id="xdx2ixbrl0550" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0649" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0650" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0655" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0656" unitRef="USD" xsi:nil="true"/>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2023-01-012023-12-31_custom_HealthCareSegmentMember" id="xdx2ixbrl0712" unitRef="USD" xsi:nil="true"/>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-012023-12-31_custom_MotorControllerMember" id="xdx2ixbrl0715" unitRef="USD" xsi:nil="true"/>

<us-gaap:CostOfRevenue contextRef="From2023-01-012023-12-31_custom_MotorControllerMember" id="xdx2ixbrl0716" unitRef="USD" xsi:nil="true"/>

<us-gaap:GrossProfit contextRef="From2023-01-012023-12-31_custom_MotorControllerMember" id="xdx2ixbrl0717" unitRef="USD" xsi:nil="true"/>

<us-gaap:OperatingIncomeLoss contextRef="From2023-01-012023-12-31_custom_MotorControllerMember" id="xdx2ixbrl0718" unitRef="USD" xsi:nil="true"/>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2023-01-012023-12-31_custom_MotorControllerMember" id="xdx2ixbrl0719" unitRef="USD" xsi:nil="true"/>

<us-gaap:Assets contextRef="AsOf2023-12-31_custom_MotorControllerMember" id="xdx2ixbrl0721" unitRef="USD" xsi:nil="true"/>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0726" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0732" unitRef="USD" xsi:nil="true"/>

<TANAF:UnallocatedAssets contextRef="AsOf2023-12-31" id="xdx2ixbrl0734" unitRef="USD" xsi:nil="true"/>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2022-01-012022-12-31_custom_HealthCareSegmentMember" id="xdx2ixbrl0743" unitRef="USD" xsi:nil="true"/>

<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0763" unitRef="USD" xsi:nil="true"/>

<TANAF:UnallocatedAssets contextRef="AsOf2022-12-31" id="xdx2ixbrl0765" unitRef="USD" xsi:nil="true"/>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember" id="xdx2ixbrl0779" unitRef="Pure" xsi:nil="true"/>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember" id="xdx2ixbrl0788" unitRef="Pure" xsi:nil="true"/>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerEMember" id="xdx2ixbrl0791" unitRef="Pure" xsi:nil="true"/>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFMember" id="xdx2ixbrl0795" unitRef="Pure" xsi:nil="true"/>

<dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="Fact000014"> 20-F </dei:DocumentType>

<dei:DocumentRegistrationStatement contextRef="From2023-01-01to2023-12-31" id="Fact000015"> false </dei:DocumentRegistrationStatement>

<dei:DocumentAnnualReport contextRef="From2023-01-01to2023-12-31" id="Fact000016"> true </dei:DocumentAnnualReport>

<dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000017"> 2023-12-31 </dei:DocumentPeriodEndDate>

<dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000018"> --12-31 </dei:CurrentFiscalYearEndDate>

<dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-12-31" id="Fact000019"> 2023 </dei:DocumentFiscalYearFocus>

<dei:DocumentTransitionReport contextRef="From2023-01-01to2023-12-31" id="Fact000020"> false </dei:DocumentTransitionReport>

<dei:DocumentShellCompanyReport contextRef="From2023-01-01to2023-12-31" id="Fact000021"> false </dei:DocumentShellCompanyReport>

<dei:EntityFileNumber contextRef="From2023-01-01to2023-12-31" id="Fact000022"> 333-267453 </dei:EntityFileNumber>

<dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000023"> TIAN’AN TECHNOLOGY GROUP LTD. </dei:EntityRegistrantName>

<dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-12-31" id="Fact000025"> Room 501 </dei:EntityAddressAddressLine1>

<dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-12-31" id="Fact000026"> No. 3, Lane 743 </dei:EntityAddressAddressLine2>

<dei:EntityAddressAddressLine3 contextRef="From2023-01-01to2023-12-31" id="Fact000027"> Taopu Road, Putuo District </dei:EntityAddressAddressLine3>

<dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-12-31" id="Fact000028"> Shanghai </dei:EntityAddressCityOrTown>

<dei:EntityAddressCountry contextRef="From2023-01-01to2023-12-31" id="Fact000029"> CN </dei:EntityAddressCountry>

<dei:ContactPersonnelName contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000030"> Heng Fei Yang </dei:ContactPersonnelName>

<dei:EntityAddressAddressLine1 contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000031"> Room 501 </dei:EntityAddressAddressLine1>

<dei:EntityAddressAddressLine2 contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000032"> No. 3, Lane 743 </dei:EntityAddressAddressLine2>

<dei:EntityAddressAddressLine3 contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000033"> Taopu Road, Putuo District </dei:EntityAddressAddressLine3>

<dei:EntityAddressCityOrTown contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000034"> Shanghai </dei:EntityAddressCityOrTown>

<dei:EntityAddressCountry contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000035"> CN </dei:EntityAddressCountry>

<dei:CityAreaCode contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000036"> 021 </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000037"> 69900680 </dei:LocalPhoneNumber>

<dei:ContactPersonnelEmailAddress contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000038"> tianankj@sina.com </dei:ContactPersonnelEmailAddress>

<dei:Security12bTitle contextRef="From2023-01-01to2023-12-31" id="Fact000039"> Ordinary Shares </dei:Security12bTitle>

<dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-12-31" decimals="INF" id="Fact000040" unitRef="Shares"> 45000000 </dei:EntityCommonStockSharesOutstanding>

<dei:EntityWellKnownSeasonedIssuer contextRef="From2023-01-01to2023-12-31" id="Fact000041"> No </dei:EntityWellKnownSeasonedIssuer>

<dei:EntityVoluntaryFilers contextRef="From2023-01-01to2023-12-31" id="Fact000042"> No </dei:EntityVoluntaryFilers>

<dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-12-31" id="Fact000043"> Yes </dei:EntityCurrentReportingStatus>

<dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-12-31" id="Fact000044"> Yes </dei:EntityInteractiveDataCurrent>

<dei:EntityFilerCategory contextRef="From2023-01-01to2023-12-31" id="Fact000045"> Non-accelerated Filer </dei:EntityFilerCategory>

<dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-12-31" id="Fact000046"> true </dei:EntityEmergingGrowthCompany>

<dei:EntityExTransitionPeriod contextRef="From2023-01-01to2023-12-31" id="Fact000047"> false </dei:EntityExTransitionPeriod>

<dei:DocumentAccountingStandard contextRef="From2023-01-01to2023-12-31" id="Fact000048"> U.S. GAAP </dei:DocumentAccountingStandard>

<dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-01-01to2023-12-31" id="Fact000049"> false </dei:DocumentFinStmtErrorCorrectionFlag>

<dei:EntityShellCompany contextRef="From2023-01-01to2023-12-31" id="Fact000050"> false </dei:EntityShellCompany>

<dei:AuditorName contextRef="From2023-01-01to2023-12-31" id="Fact000051"> HHC </dei:AuditorName>

<dei:AuditorLocation contextRef="From2023-01-01to2023-12-31" id="Fact000052"> Forest Hills, New York </dei:AuditorLocation>

<dei:AuditorFirmId contextRef="From2023-01-01to2023-12-31" id="Fact000053"> 5867 </dei:AuditorFirmId>

<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2023-12-31" decimals="0" id="Fact000061" unitRef="USD"> 3058 </us-gaap:CashAndCashEquivalentsAtCarryingValue>

<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" id="Fact000062" unitRef="USD"> 15005 </us-gaap:CashAndCashEquivalentsAtCarryingValue>

<us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000064" unitRef="USD"> 2618 </us-gaap:AccountsReceivableNetCurrent>

<us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000067" unitRef="USD"> 635 </us-gaap:OtherReceivablesNetCurrent>

<us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000068" unitRef="USD"> 1461 </us-gaap:OtherReceivablesNetCurrent>

<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000070" unitRef="USD"> 170922 </us-gaap:PrepaidExpenseCurrent>

<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000071" unitRef="USD"> 58236 </us-gaap:PrepaidExpenseCurrent>

<us-gaap:AssetsCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000073" unitRef="USD"> 177233 </us-gaap:AssetsCurrent>

<us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000074" unitRef="USD"> 74702 </us-gaap:AssetsCurrent>

<us-gaap:AccountsPayableCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000083" unitRef="USD"> 83 </us-gaap:AccountsPayableCurrent>

<us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000085" unitRef="USD"> 7874 </us-gaap:AccruedPayrollTaxesCurrent>

<us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000086" unitRef="USD"> 8002 </us-gaap:AccruedPayrollTaxesCurrent>

<us-gaap:TaxesPayableCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000089" unitRef="USD"> 1570 </us-gaap:TaxesPayableCurrent>

<us-gaap:ShortTermBorrowings contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember" decimals="0" id="Fact000091" unitRef="USD"> 31768 </us-gaap:ShortTermBorrowings>

<us-gaap:ShortTermBorrowings contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember" decimals="0" id="Fact000092" unitRef="USD"> 25803 </us-gaap:ShortTermBorrowings>

<us-gaap:ShortTermBorrowings contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000094" unitRef="USD"> 366919 </us-gaap:ShortTermBorrowings>

<us-gaap:ShortTermBorrowings contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000095" unitRef="USD"> 1703 </us-gaap:ShortTermBorrowings>

<us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000097" unitRef="USD"> 97138 </us-gaap:OtherLiabilitiesCurrent>

<us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000098" unitRef="USD"> 220054 </us-gaap:OtherLiabilitiesCurrent>

<us-gaap:OtherNotesPayableCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000100" unitRef="USD"> 110298 </us-gaap:OtherNotesPayableCurrent>

<us-gaap:OtherNotesPayableCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000101" unitRef="USD"> 124986 </us-gaap:OtherNotesPayableCurrent>

<TANAF:SharesToBeIssued contextRef="AsOf2023-12-31" decimals="0" id="Fact000103" unitRef="USD"> 107200 </TANAF:SharesToBeIssued>

<us-gaap:Liabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000106" unitRef="USD"> 721197 </us-gaap:Liabilities>

<us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000107" unitRef="USD"> 382201 </us-gaap:Liabilities>

<us-gaap:CommonStockNoParValue contextRef="AsOf2023-12-31" decimals="INF" id="Fact000118" unitRef="USDPShares"> 0 </us-gaap:CommonStockNoParValue>

<us-gaap:CommonStockNoParValue contextRef="AsOf2022-12-31" decimals="INF" id="Fact000120" unitRef="USDPShares"> 0 </us-gaap:CommonStockNoParValue>

<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-12-31" decimals="INF" id="Fact000122" unitRef="Shares"> 100000000 </us-gaap:CommonStockSharesAuthorized>

<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" id="Fact000124" unitRef="Shares"> 100000000 </us-gaap:CommonStockSharesAuthorized>

<us-gaap:CommonStockSharesIssued contextRef="AsOf2023-12-31" decimals="INF" id="Fact000126" unitRef="Shares"> 45000000 </us-gaap:CommonStockSharesIssued>

<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-12-31" decimals="INF" id="Fact000128" unitRef="Shares"> 45000000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:CommonStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" id="Fact000130" unitRef="Shares"> 45000000 </us-gaap:CommonStockSharesIssued>

<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" id="Fact000132" unitRef="Shares"> 45000000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-12-31" decimals="0" id="Fact000134" unitRef="USD"> 500000 </us-gaap:AdditionalPaidInCapital>

<us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-12-31" decimals="0" id="Fact000135" unitRef="USD"> 500000 </us-gaap:AdditionalPaidInCapital>

<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-12-31" decimals="0" id="Fact000137" unitRef="USD"> -1064348 </us-gaap:RetainedEarningsAccumulatedDeficit>

<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="0" id="Fact000138" unitRef="USD"> -814339 </us-gaap:RetainedEarningsAccumulatedDeficit>

<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2023-12-31" decimals="0" id="Fact000140" unitRef="USD"> 20384 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>

<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-12-31" decimals="0" id="Fact000141" unitRef="USD"> 6840 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31" decimals="0" id="Fact000143" unitRef="USD"> -543964 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" id="Fact000144" unitRef="USD"> -307499 </us-gaap:StockholdersEquity>

<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-12-31" decimals="0" id="Fact000146" unitRef="USD"> 177233 </us-gaap:LiabilitiesAndStockholdersEquity>

<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="0" id="Fact000147" unitRef="USD"> 74702 </us-gaap:LiabilitiesAndStockholdersEquity>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember" decimals="0" id="Fact000149" unitRef="USD"> 182584 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember" decimals="0" id="Fact000150" unitRef="USD"> 163391 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000152" unitRef="USD"> 64035 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000153" unitRef="USD"> 32342 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000155" unitRef="USD"> 246619 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000156" unitRef="USD"> 195733 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:CostOfRevenue contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember" decimals="0" id="Fact000158" unitRef="USD"> 130998 </us-gaap:CostOfRevenue>

<us-gaap:CostOfRevenue contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember" decimals="0" id="Fact000159" unitRef="USD"> 120978 </us-gaap:CostOfRevenue>

<us-gaap:CostOfRevenue contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000161" unitRef="USD"> 48940 </us-gaap:CostOfRevenue>

<us-gaap:CostOfRevenue contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember" decimals="0" id="Fact000162" unitRef="USD"> 21927 </us-gaap:CostOfRevenue>

<us-gaap:CostOfRevenue contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000164" unitRef="USD"> 179938 </us-gaap:CostOfRevenue>

<us-gaap:CostOfRevenue contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000165" unitRef="USD"> 142905 </us-gaap:CostOfRevenue>

<us-gaap:GrossProfit contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000167" unitRef="USD"> 66681 </us-gaap:GrossProfit>

<us-gaap:GrossProfit contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000168" unitRef="USD"> 52828 </us-gaap:GrossProfit>

<us-gaap:ResearchAndDevelopmentExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000174" unitRef="USD"> 10945 </us-gaap:ResearchAndDevelopmentExpense>

<us-gaap:SellingAndMarketingExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000176" unitRef="USD"> 40225 </us-gaap:SellingAndMarketingExpense>

<us-gaap:SellingAndMarketingExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000177" unitRef="USD"> 12917 </us-gaap:SellingAndMarketingExpense>

<us-gaap:GeneralAndAdministrativeExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000179" unitRef="USD"> 275781 </us-gaap:GeneralAndAdministrativeExpense>

<us-gaap:GeneralAndAdministrativeExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000180" unitRef="USD"> 307691 </us-gaap:GeneralAndAdministrativeExpense>

<us-gaap:OperatingExpenses contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000182" unitRef="USD"> 316006 </us-gaap:OperatingExpenses>

<us-gaap:OperatingExpenses contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000183" unitRef="USD"> 331553 </us-gaap:OperatingExpenses>

<us-gaap:OperatingIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000185" unitRef="USD"> -249325 </us-gaap:OperatingIncomeLoss>

<us-gaap:OperatingIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000186" unitRef="USD"> -278725 </us-gaap:OperatingIncomeLoss>

<us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000191" unitRef="USD"> 24 </us-gaap:InterestIncomeExpenseNonoperatingNet>

<us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000192" unitRef="USD"> 61 </us-gaap:InterestIncomeExpenseNonoperatingNet>

<us-gaap:OtherNonoperatingExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000194" unitRef="USD"> 708 </us-gaap:OtherNonoperatingExpense>

<us-gaap:OtherNonoperatingExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000195" unitRef="USD"> 1853 </us-gaap:OtherNonoperatingExpense>

<us-gaap:NonoperatingIncomeExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000197" unitRef="USD"> -684 </us-gaap:NonoperatingIncomeExpense>

<us-gaap:NonoperatingIncomeExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000198" unitRef="USD"> -1792 </us-gaap:NonoperatingIncomeExpense>

<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000200" unitRef="USD"> -250009 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000201" unitRef="USD"> -280517 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

<us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000206" unitRef="USD"> -250009 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000207" unitRef="USD"> -280517 </us-gaap:NetIncomeLoss>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000212" unitRef="USD"> 13544 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000213" unitRef="USD"> 44546 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>

<us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000215" unitRef="USD"> -236465 </us-gaap:ComprehensiveIncomeNetOfTax>

<us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000216" unitRef="USD"> -235971 </us-gaap:ComprehensiveIncomeNetOfTax>

<us-gaap:EarningsPerShareBasic contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000218" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>

<us-gaap:EarningsPerShareDiluted contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000220" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>

<us-gaap:EarningsPerShareBasic contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000222" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>

<us-gaap:EarningsPerShareDiluted contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000224" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000226" unitRef="Shares"> 45000000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000228" unitRef="Shares"> 45000000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000230" unitRef="Shares"> 41821918 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000232" unitRef="Shares"> 41821918 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000240" unitRef="Shares"> 40000000 </us-gaap:SharesOutstanding>

<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000236" unitRef="USD"> -533822 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000237" unitRef="USD"> -37706 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" id="Fact000238" unitRef="USD"> -571528 </us-gaap:StockholdersEquity>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000244" unitRef="USD"> -280517 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000246" unitRef="USD"> -280517 </us-gaap:NetIncomeLoss>

<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000254" unitRef="Shares"> 5000000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact000249" unitRef="USD"> 500000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000252" unitRef="USD"> 500000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000259" unitRef="USD"> 44546 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000260" unitRef="USD"> 44546 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>

<us-gaap:SharesOutstanding contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000268" unitRef="Shares"> 45000000 </us-gaap:SharesOutstanding>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact000263" unitRef="USD"> 500000 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000264" unitRef="USD"> -814339 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000265" unitRef="USD"> 6840 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" id="Fact000266" unitRef="USD"> -307499 </us-gaap:StockholdersEquity>

<us-gaap:SharesOutstanding contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000276" unitRef="Shares"> 45000000 </us-gaap:SharesOutstanding>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact000271" unitRef="USD"> 500000 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000272" unitRef="USD"> -814339 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000273" unitRef="USD"> 6840 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" id="Fact000274" unitRef="USD"> -307499 </us-gaap:StockholdersEquity>

<us-gaap:NetIncomeLoss contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000280" unitRef="USD"> -250009 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000282" unitRef="USD"> -250009 </us-gaap:NetIncomeLoss>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2023-01-012023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000287" unitRef="USD"> 13544 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000288" unitRef="USD"> 13544 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>

<us-gaap:SharesOutstanding contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000296" unitRef="Shares"> 45000000 </us-gaap:SharesOutstanding>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact000291" unitRef="USD"> 500000 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000292" unitRef="USD"> -1064348 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000293" unitRef="USD"> 20384 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31" decimals="0" id="Fact000294" unitRef="USD"> -543964 </us-gaap:StockholdersEquity>

<us-gaap:SharesOutstanding contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000304" unitRef="Shares"> 45000000 </us-gaap:SharesOutstanding>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="Fact000299" unitRef="USD"> 500000 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" decimals="0" id="Fact000300" unitRef="USD"> -1064348 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" id="Fact000301" unitRef="USD"> 20384 </us-gaap:StockholdersEquity>

<us-gaap:StockholdersEquity contextRef="AsOf2023-12-31" decimals="0" id="Fact000302" unitRef="USD"> -543964 </us-gaap:StockholdersEquity>

<us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000309" unitRef="USD"> -250009 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000310" unitRef="USD"> -280517 </us-gaap:NetIncomeLoss>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000316" unitRef="USD"> 5470 </us-gaap:DepreciationDepletionAndAmortization>

<us-gaap:GainLossOnDispositionOfAssets1 contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000319" unitRef="USD"> -978 </us-gaap:GainLossOnDispositionOfAssets1>

<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000321" unitRef="USD"> 2639 </us-gaap:IncreaseDecreaseInAccountsReceivable>

<us-gaap:IncreaseDecreaseInOtherReceivables contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000324" unitRef="USD"> -794 </us-gaap:IncreaseDecreaseInOtherReceivables>

<us-gaap:IncreaseDecreaseInOtherReceivables contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000325" unitRef="USD"> -480 </us-gaap:IncreaseDecreaseInOtherReceivables>

<us-gaap:IncreaseDecreaseInInventories contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000328" unitRef="USD"> -30209 </us-gaap:IncreaseDecreaseInInventories>

<us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000330" unitRef="USD"> -115124 </us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>

<us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000331" unitRef="USD"> -44320 </us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>

<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000333" unitRef="USD"> -82 </us-gaap:IncreaseDecreaseInAccountsPayableTrade>

<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000334" unitRef="USD"> 85 </us-gaap:IncreaseDecreaseInAccountsPayableTrade>

<us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000336" unitRef="USD"> -374898 </us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>

<us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000337" unitRef="USD"> -27739 </us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>

<us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000339" unitRef="USD"> 81 </us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>

<us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000340" unitRef="USD"> -21691 </us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>

<us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000342" unitRef="USD"> -1542 </us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>

<us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000343" unitRef="USD"> 12544 </us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>

<us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000346" unitRef="USD"> -4461 </us-gaap:IncreaseDecreaseInOperatingLeaseLiability>

<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000348" unitRef="USD"> -11526 </us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>

<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000349" unitRef="USD"> 128065 </us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>

<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000351" unitRef="USD"> -5149 </us-gaap:NetCashProvidedByUsedInOperatingActivities>

<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000352" unitRef="USD"> -145419 </us-gaap:NetCashProvidedByUsedInOperatingActivities>

<TANAF:ProceedsFromSharesToBeIssued contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000357" unitRef="USD"> 107200 </TANAF:ProceedsFromSharesToBeIssued>

<us-gaap:ProceedsFromContributedCapital contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000361" unitRef="USD"> 505121 </us-gaap:ProceedsFromContributedCapital>

<us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000363" unitRef="USD"> 130943 </us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>

<us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000364" unitRef="USD"> 312367 </us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000366" unitRef="USD"> 249076 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000367" unitRef="USD"> 553810 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000370" unitRef="USD"> -103974 </us-gaap:ProceedsFromRepaymentsOfNotesPayable>

<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000372" unitRef="USD"> -10933 </us-gaap:NetCashProvidedByUsedInFinancingActivities>

<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000373" unitRef="USD"> 159704 </us-gaap:NetCashProvidedByUsedInFinancingActivities>

<us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000379" unitRef="USD"> 163 </us-gaap:ProceedsFromSaleOfProductiveAssets>

<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000382" unitRef="USD"> 163 </us-gaap:NetCashProvidedByUsedInInvestingActivities>

<us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000384" unitRef="USD"> 4135 </us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>

<us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000385" unitRef="USD"> 101 </us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000387" unitRef="USD"> -11947 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000388" unitRef="USD"> 14549 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-12-31" decimals="0" id="Fact000390" unitRef="USD"> 15005 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="0" id="Fact000391" unitRef="USD"> 456 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2023-12-31" decimals="0" id="Fact000393" unitRef="USD"> 3058 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>

<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-12-31" decimals="0" id="Fact000394" unitRef="USD"> 15005 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>

<us-gaap:InterestPaidNet contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000399" unitRef="USD"> 24 </us-gaap:InterestPaidNet>

<us-gaap:InterestPaidNet contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000400" unitRef="USD"> 61 </us-gaap:InterestPaidNet>

<TANAF:ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000412" unitRef="USD"> 9048 </TANAF:ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases>

<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000414">

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The Consolidated Financial Statements include data of Tian’an Technology Group Ltd. (“Tian’an”), a holding company incorporated in the British Virgin Islands on April 8, 2021; Yunke Jingrong Information Technology, Co., Ltd. (“Yunke”), a holding company incorporated in Hong Kong on October 27, 2021 and Shanghai Qige Power Technology Co., Ltd. (“Shanghai Qige”), an operating company incorporated in China (PRC) on August 10, 2016. Shanghai Qige is a wholly owned subsidiary of Yunke, which is a wholly owned subsidiary of Tian’an. Tian’an, Yunke and Shanghai Qige are collectively referred to as “the Company”. Currently, all of the Company’s operations are conducted through its subsidiary Shanghai Qige. Tian’an and Yunke are holding companies and have no operations. Through, Shanghai Qige, we were engaged in the technology driven sales of power control and service systems solutions. In the third quarter of 2022, the Company shifted its business model and through Shanghai Qige, focused on graphene production enterprises and engaged in the health therapy industry. We utilize the far-infrared heat therapy characteristics of graphene, which is incorporated into our products. The Company’s initial marketing efforts are in the Eastern China market with the intention of developing a nationwide marketing network. The Company has developed a reputation of excellence in product quality and after sales service. SCHEDULE OF CONSOLIDATED COMPANIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 28%">Name of Consolidated Companies</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 18%">Domicile and Date of Incorporation</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 12%">Paid in Capital</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 18%">Percentage of Effective Ownership</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 16%">Principal Activities</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tian’an Technology Group Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zcKClH8hntvc" title="Date of Incorporation">April 8, 2021, <span id="xdx_90D_ecustom--EntityIncorporationStateCountryDescription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zRUnoyxf3iW7" title="Domicile of Incorporation">British Virgin Islands</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">USD $<span id="xdx_90E_eus-gaap--AdditionalPaidInCapital_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zKNRwdQ6Zsol" title="Paid in capital">0</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_ztJeulCMUdKj" title="Percentage of effective ownership">89% owned by Mr. Heng Fei Yang</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zVjdR4VseOCi" title="Percent principal activities">Investment holding</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Yunke Jingrong Information Technology Co., Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zbM5rw2h8iqi" title="Date of Incorporation">October 27, 2021, <span id="xdx_900_ecustom--EntityIncorporationStateCountryDescription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zxq3q1riuDf1" title="Domicile of Incorporation">PRC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">USD $<span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zxpQljUnAGGe" title="Paid in capital">0</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zuOUIqwC5d5g" title="Percentage of effective ownership">100% owned by Tian’an</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zgmyvr6fytZe" title="Percent principal activities">Investment holding</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shanghai Quige Power Technology Co., Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zFmSXaEecch2" title="Date of Incorporation">August 10, 2016, <span id="xdx_903_ecustom--EntityIncorporationStateCountryDescription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zQaJHoRnW9Ti" title="Domicile of Incorporation">PRC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">USD $<span id="xdx_90A_eus-gaap--AdditionalPaidInCapital_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zSmlDrXKCLOa" title="Paid in capital">0</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zZyOFGORNabf" title="Percentage of effective ownership">100% owned by Yunke Jingrong</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zhbyceM5BBB4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Production and distribution of power drive product systems and distribution of healthcare products</td></tr> </table> Basis of Presentation and Principles of Consolidation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the Company and its wholly-owned subsidiary. The Company’s functional currency is the Chinese Renminbi (“RMB”); however, the accompanying consolidated financial statements have been translated and presented in United States Dollars (“USD”). All significant inter-company accounts and transactions have been eliminated. The consolidated financial statements include all adjustments that, in the opinion of management, are necessary to make the financial statements not misleading. Use of Estimates and Assumptions The preparation of financial statements in conformity with US GAAP requires Management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Significant estimates and assumptions by Management include, among others, useful life and impairment analysis of long-lived assets, valuation of inventory and right-of-use assets and liabilities, allowance for credit loss of financial assets, other receivables and prepayments. While Management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Concentrations of Business and Credit Risks All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Moreover, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations. The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between United States dollars (“USD”) and the Chinese currency Renminbi (“RMB”). The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting periods. Statements of Cash Flows In accordance with Statement FASB ASC Topic 230, “Statement of Cash Flows”, cash flow from the Company’s operations is calculated based upon the local currencies and translated to the reporting currency using an average foreign exchange rate for the reporting period. As a result, amounts related to assets and liabilities reported in the statements of cash flows will not necessarily be the same as the corresponding balances on the consolidated balance sheets. Cash Cash consist primarily of cash on hand and cash in banks which is readily available in checking and saving accounts. The Company maintains cash with various financial institutions in the PRC where its accounts are uninsured. The Company has not experienced any losses from funds held in bank accounts and believes it is not exposed to any risk on its bank accounts. Advances to Suppliers The Company periodically makes advances to certain vendors for purchases of raw materials or to service providers for services and records these payments as advances to suppliers. As of December 31, 2023 and 2022, advances to suppliers amounted to $170,922 and $58,236, respectively. Inventories Inventories are stated at the lower of cost and net realizable value. The Company used the weighted average cost method of accounting for inventories. The Company regularly evaluates the composition of its inventories to identify slow-moving and obsolete inventories to determine whether valuation allowance is required. As of December 31, 2023 and 2022, the Company did not record inventory valuation allowance. Leases The Company leases space from third parties for its plant sites and/or office space. In accordance with Statement FASB ASC Topic 842, the Company recognizes a right-of-use asset and lease liability at the commencement date of the of the lease contract and recognizes in profit or loss the lease cost or expense during the lease term. As an accounting policy, the Company elects not to recognize a right-of-use asset and lease liability requirement to short-term leases, which with a term of 12 months or less, instead, recognizes the lease payments in profit or loss on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred. The Company generally uses an incremental borrowing rate as discount rate to measure its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company’s control. The Company includes optional renewal periods in the lease term only when it is reasonably certain that the Company will exercise its option. Variable lease payments include payments to lessors for taxes, maintenance, insurance and other operating costs as well as payments that are adjusted based on an index or rate. The company’s lease agreements do not contain any significant residual value guarantees or restrictive covenants. Revenue Recognition We adopted Accounting Standard Codification (“ASC”) Topic 606, Revenues from Contract with Customers (“ASC 606”) for all periods presented. Under ASC 606, revenue is recognized when control of the promised goods and services is transferred to the Company’s customers, in an amount that reflects the consideration that we expect to be entitled to in exchange for those goods and services, net of value-added tax. We determine revenue recognition through the following steps: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Identify the contract with a customer;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Identify the performance obligations in the contract;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Determine the transaction price;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Allocate the transaction price to the performance obligations in the contract; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Recognize revenue when (or as) the entity satisfies a performance obligation.</td></tr> </table> The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized when that performance obligation is satisfied by the control of the promised goods and services is transferred to the customers, which at a point in time or over time as appropriate. All performance obligation were satisfied at a point in time and related revenues from contract with customers were recognized at point in time for the year ended December 31, 2023 and 2022, respectively. Our revenues are net of value added tax (“VAT”) collected on behalf of PRC tax authorities in respect to the sales of merchandise. VAT collected from customers, net of VAT paid for purchases, is recorded as a liability in the accompanying consolidated balance sheets until it is paid to the relevant PRC tax authorities. Fair Value of Financial Instruments The Company measures its financial and non-financial assets and liabilities, as well as makes related disclosures, in accordance with FASB Accounting Standards Codification No. 820, Fair Value Measurement (“ASC 820”), which provides guidance with respect to valuation techniques to be utilized in the determination of fair value of assets and liabilities. Approaches include, (i) the market approach (comparable market prices), (ii) the income approach (present value of future income or cash flow), and (iii) the cost approach (cost to replace the service capacity of an asset or replacement cost). ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists. The Company’s financial instruments include cash, accounts receivable, other receivables, advance to suppliers, accounts payable, amount due from/to related parties, advances from customers and other current liabilities. The carrying values of these financial instruments approximate their fair values due to their short-term maturities. Loss per Common Share The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the year. The diluted loss per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted loss per share is the same as basic loss per share due to the lack of dilutive instruments in the Company. For the years ended December 31, 2023 and 2022, the Company had no potential dilutive common stock equivalents outstanding. Income Taxes The Company is governed by the Income Tax Law and associated legislations of the PRC. The Company accounts for income taxes in accordance with FASB ASC 740 “Income Taxes” (formerly SFAS No. 109 Accounting for Income Taxes), which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. ASC 740 additionally requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets. Realization of deferred tax assets is dependent upon future earnings, if any, of which the timing and amount are uncertain. According to ASC 740, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition. Translation of Foreign Currencies For subsidiaries where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders’ equity, into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive loss as a component of shareholders’ equity in the consolidated balance sheet. <p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zET1Grth5vQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> SCHEDULE OF TRANSLATION OF FOREIGN CURRENCIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zR1FZ99qkO36" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_ztxjcTw7OVZd" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_hus-gaap--AwardTypeAxis__custom--YearEndedRMBUSDExchangeRateMember_zJWPC427ULBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Year ended RMB: USD Exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.1412</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.1450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_hus-gaap--AwardTypeAxis__custom--AverageYearlyRMBUSDExchangeRateMember_znG8eMu6rZn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Average yearly RMB: USD Exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1485</td><td style="text-align: left"> </td></tr> </table> The RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions. No representation is made that the RMB amounts could have been, or could be, converted into USD at the rates used in translation. For the years ended December 31, 2023 and 2022 foreign currency translation adjustments of $13,544 and $44,546 respectively, have been reported as other comprehensive loss in the consolidated financial statements. Other Comprehensive Income Other comprehensive income is defined as the change in equity during the period from transactions and other events, excluding the changes resulting from investments by owners and distributions to owners. Other comprehensive income is not included in the computation of income tax expense or benefit. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Segment Information The Company follows FASB ASC 280-Segment Reporting, which requires that companies disclose segment data based on how management makes decision about allocating resources to segments and evaluating their performance. For the year ended December 31, 2023, the Company is operating in one reportable business segment, Healthcare. For the year ended December 31, 2022, management has determined that the Company is operating in two reportable business segments, Healthcare and Motor Controller. The Company’s reportable segments are strategic business units that offer different products. They are managed separately based on the fundamental differences in their operations. Recent Accounting Pronouncements The Company is an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. As a result, the Group’s operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards. In November 2023, the Financial Accounting Standards Board (“FASB”) issued a new standard to improve reportable segment disclosures. The guidance expands the disclosures required for reportable segments in our annual and interim consolidated financial statements, primarily through enhanced disclosures about significant segment expenses. The standard will be effective for us beginning with our annual reporting for fiscal year 2025 and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of this standard on our segment disclosures. In December 2023, the FASB issued a new standard to improve income tax disclosures. The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The standard will be effective for us beginning with our annual reporting for fiscal year 2026, with early adoption permitted. We are currently evaluating the impact of this standard on our income tax disclosures. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>

<TANAF:ScheduleOfConsolidatedCompaniesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000416">

The Company’s initial marketing efforts are in the Eastern China market with the intention of developing a nationwide marketing network. The Company has developed a reputation of excellence in product quality and after sales service. SCHEDULE OF CONSOLIDATED COMPANIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 28%">Name of Consolidated Companies</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 18%">Domicile and Date of Incorporation</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 12%">Paid in Capital</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 18%">Percentage of Effective Ownership</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 16%">Principal Activities</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tian’an Technology Group Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zcKClH8hntvc" title="Date of Incorporation">April 8, 2021, <span id="xdx_90D_ecustom--EntityIncorporationStateCountryDescription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zRUnoyxf3iW7" title="Domicile of Incorporation">British Virgin Islands</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">USD $<span id="xdx_90E_eus-gaap--AdditionalPaidInCapital_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zKNRwdQ6Zsol" title="Paid in capital">0</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_ztJeulCMUdKj" title="Percentage of effective ownership">89% owned by Mr. Heng Fei Yang</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TiananTechnologyGroupLtdMember_zVjdR4VseOCi" title="Percent principal activities">Investment holding</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Yunke Jingrong Information Technology Co., Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zbM5rw2h8iqi" title="Date of Incorporation">October 27, 2021, <span id="xdx_900_ecustom--EntityIncorporationStateCountryDescription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zxq3q1riuDf1" title="Domicile of Incorporation">PRC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">USD $<span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zxpQljUnAGGe" title="Paid in capital">0</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zuOUIqwC5d5g" title="Percentage of effective ownership">100% owned by Tian’an</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--YunkeJingrongInformationTechnologyCoLtdMember_zgmyvr6fytZe" title="Percent principal activities">Investment holding</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shanghai Quige Power Technology Co., Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zFmSXaEecch2" title="Date of Incorporation">August 10, 2016, <span id="xdx_903_ecustom--EntityIncorporationStateCountryDescription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zQaJHoRnW9Ti" title="Domicile of Incorporation">PRC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">USD $<span id="xdx_90A_eus-gaap--AdditionalPaidInCapital_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zSmlDrXKCLOa" title="Paid in capital">0</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zZyOFGORNabf" title="Percentage of effective ownership">100% owned by Yunke Jingrong</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ShanghaiQuigePowerTechnologyCoLtdMember_zhbyceM5BBB4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Production and distribution of power drive product systems and distribution of healthcare products</td></tr> </table>

</TANAF:ScheduleOfConsolidatedCompaniesTextBlock>

<dei:EntityIncorporationDateOfIncorporation contextRef="From2023-01-012023-12-31_custom_TiananTechnologyGroupLtdMember" id="Fact000418"> 2021-04-08 </dei:EntityIncorporationDateOfIncorporation>

<TANAF:EntityIncorporationStateCountryDescription contextRef="From2023-01-012023-12-31_custom_TiananTechnologyGroupLtdMember" id="Fact000420"> British Virgin Islands </TANAF:EntityIncorporationStateCountryDescription>

<us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-12-31_custom_TiananTechnologyGroupLtdMember" decimals="0" id="Fact000422" unitRef="USD"> 0 </us-gaap:AdditionalPaidInCapital>

<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2023-12-31_custom_TiananTechnologyGroupLtdMember" decimals="INF" id="Fact000424" unitRef="Pure"> 0.89 </us-gaap:EquityMethodInvestmentOwnershipPercentage>

<us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities contextRef="From2023-01-012023-12-31_custom_TiananTechnologyGroupLtdMember" id="Fact000426"> Investment holding </us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities>

<dei:EntityIncorporationDateOfIncorporation contextRef="From2023-01-012023-12-31_custom_YunkeJingrongInformationTechnologyCoLtdMember" id="Fact000428"> 2021-10-27 </dei:EntityIncorporationDateOfIncorporation>

<TANAF:EntityIncorporationStateCountryDescription contextRef="From2023-01-012023-12-31_custom_YunkeJingrongInformationTechnologyCoLtdMember" id="Fact000430"> PRC </TANAF:EntityIncorporationStateCountryDescription>

<us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-12-31_custom_YunkeJingrongInformationTechnologyCoLtdMember" decimals="0" id="Fact000432" unitRef="USD"> 0 </us-gaap:AdditionalPaidInCapital>

<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2023-12-31_custom_YunkeJingrongInformationTechnologyCoLtdMember" decimals="INF" id="Fact000434" unitRef="Pure"> 1 </us-gaap:EquityMethodInvestmentOwnershipPercentage>

<us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities contextRef="From2023-01-012023-12-31_custom_YunkeJingrongInformationTechnologyCoLtdMember" id="Fact000436"> Investment holding </us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities>

<dei:EntityIncorporationDateOfIncorporation contextRef="From2023-01-012023-12-31_custom_ShanghaiQuigePowerTechnologyCoLtdMember" id="Fact000438"> 2016-08-10 </dei:EntityIncorporationDateOfIncorporation>

<TANAF:EntityIncorporationStateCountryDescription contextRef="From2023-01-012023-12-31_custom_ShanghaiQuigePowerTechnologyCoLtdMember" id="Fact000440"> PRC </TANAF:EntityIncorporationStateCountryDescription>

<us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-12-31_custom_ShanghaiQuigePowerTechnologyCoLtdMember" decimals="0" id="Fact000442" unitRef="USD"> 0 </us-gaap:AdditionalPaidInCapital>

<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2023-12-31_custom_ShanghaiQuigePowerTechnologyCoLtdMember" decimals="INF" id="Fact000444" unitRef="Pure"> 1 </us-gaap:EquityMethodInvestmentOwnershipPercentage>

<us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities contextRef="From2023-01-012023-12-31_custom_ShanghaiQuigePowerTechnologyCoLtdMember" id="Fact000445"> Production and distribution of power drive product systems and distribution of healthcare products </us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities>

<us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000447">

Basis of Presentation and Principles of Consolidation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the Company and its wholly-owned subsidiary. The Company’s functional currency is the Chinese Renminbi (“RMB”); however, the accompanying consolidated financial statements have been translated and presented in United States Dollars (“USD”). All significant inter-company accounts and transactions have been eliminated. The consolidated financial statements include all adjustments that, in the opinion of management, are necessary to make the financial statements not misleading.

</us-gaap:ConsolidationPolicyTextBlock>

<us-gaap:UseOfEstimates contextRef="From2023-01-01to2023-12-31" id="Fact000449">

Use of Estimates and Assumptions The preparation of financial statements in conformity with US GAAP requires Management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Significant estimates and assumptions by Management include, among others, useful life and impairment analysis of long-lived assets, valuation of inventory and right-of-use assets and liabilities, allowance for credit loss of financial assets, other receivables and prepayments. While Management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.

</us-gaap:UseOfEstimates>

<us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-01-01to2023-12-31" id="Fact000451">

Concentrations of Business and Credit Risks All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Moreover, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations. The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between United States dollars (“USD”) and the Chinese currency Renminbi (“RMB”). The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting periods.

</us-gaap:ConcentrationRiskCreditRisk>

<us-gaap:InventoryCashFlowPolicy contextRef="From2023-01-01to2023-12-31" id="Fact000453">

Statements of Cash Flows In accordance with Statement FASB ASC Topic 230, “Statement of Cash Flows”, cash flow from the Company’s operations is calculated based upon the local currencies and translated to the reporting currency using an average foreign exchange rate for the reporting period. As a result, amounts related to assets and liabilities reported in the statements of cash flows will not necessarily be the same as the corresponding balances on the consolidated balance sheets.

</us-gaap:InventoryCashFlowPolicy>

<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000455">

Cash Cash consist primarily of cash on hand and cash in banks which is readily available in checking and saving accounts. The Company maintains cash with various financial institutions in the PRC where its accounts are uninsured. The Company has not experienced any losses from funds held in bank accounts and believes it is not exposed to any risk on its bank accounts.

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>

<TANAF:AdvancesToSuppliersPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000457">

Advances to Suppliers The Company periodically makes advances to certain vendors for purchases of raw materials or to service providers for services and records these payments as advances to suppliers. As of December 31, 2023 and 2022, advances to suppliers amounted to $170,922 and $58,236, respectively.

</TANAF:AdvancesToSuppliersPolicyTextBlock>

<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000458" unitRef="USD"> 170922 </us-gaap:PrepaidExpenseCurrent>

<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000459" unitRef="USD"> 58236 </us-gaap:PrepaidExpenseCurrent>

<us-gaap:InventoryPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000461">

Inventories Inventories are stated at the lower of cost and net realizable value. The Company used the weighted average cost method of accounting for inventories. The Company regularly evaluates the composition of its inventories to identify slow-moving and obsolete inventories to determine whether valuation allowance is required. As of December 31, 2023 and 2022, the Company did not record inventory valuation allowance.

</us-gaap:InventoryPolicyTextBlock>

<us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000463">

Leases The Company leases space from third parties for its plant sites and/or office space. In accordance with Statement FASB ASC Topic 842, the Company recognizes a right-of-use asset and lease liability at the commencement date of the of the lease contract and recognizes in profit or loss the lease cost or expense during the lease term. As an accounting policy, the Company elects not to recognize a right-of-use asset and lease liability requirement to short-term leases, which with a term of 12 months or less, instead, recognizes the lease payments in profit or loss on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred. The Company generally uses an incremental borrowing rate as discount rate to measure its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company’s control. The Company includes optional renewal periods in the lease term only when it is reasonably certain that the Company will exercise its option. Variable lease payments include payments to lessors for taxes, maintenance, insurance and other operating costs as well as payments that are adjusted based on an index or rate. The company’s lease agreements do not contain any significant residual value guarantees or restrictive covenants.

</us-gaap:LesseeLeasesPolicyTextBlock>

<us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000465">

Revenue Recognition We adopted Accounting Standard Codification (“ASC”) Topic 606, Revenues from Contract with Customers (“ASC 606”) for all periods presented. Under ASC 606, revenue is recognized when control of the promised goods and services is transferred to the Company’s customers, in an amount that reflects the consideration that we expect to be entitled to in exchange for those goods and services, net of value-added tax. We determine revenue recognition through the following steps: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Identify the contract with a customer;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Identify the performance obligations in the contract;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Determine the transaction price;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Allocate the transaction price to the performance obligations in the contract; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Recognize revenue when (or as) the entity satisfies a performance obligation.</td></tr> </table> The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized when that performance obligation is satisfied by the control of the promised goods and services is transferred to the customers, which at a point in time or over time as appropriate. All performance obligation were satisfied at a point in time and related revenues from contract with customers were recognized at point in time for the year ended December 31, 2023 and 2022, respectively. Our revenues are net of value added tax (“VAT”) collected on behalf of PRC tax authorities in respect to the sales of merchandise. VAT collected from customers, net of VAT paid for purchases, is recorded as a liability in the accompanying consolidated balance sheets until it is paid to the relevant PRC tax authorities.

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>

<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-01to2023-12-31" id="Fact000467">

Fair Value of Financial Instruments The Company measures its financial and non-financial assets and liabilities, as well as makes related disclosures, in accordance with FASB Accounting Standards Codification No. 820, Fair Value Measurement (“ASC 820”), which provides guidance with respect to valuation techniques to be utilized in the determination of fair value of assets and liabilities. Approaches include, (i) the market approach (comparable market prices), (ii) the income approach (present value of future income or cash flow), and (iii) the cost approach (cost to replace the service capacity of an asset or replacement cost). ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists. The Company’s financial instruments include cash, accounts receivable, other receivables, advance to suppliers, accounts payable, amount due from/to related parties, advances from customers and other current liabilities. The carrying values of these financial instruments approximate their fair values due to their short-term maturities.

</us-gaap:FairValueOfFinancialInstrumentsPolicy>

<us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000469">

Loss per Common Share The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the year. The diluted loss per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted loss per share is the same as basic loss per share due to the lack of dilutive instruments in the Company. For the years ended December 31, 2023 and 2022, the Company had no potential dilutive common stock equivalents outstanding.

</us-gaap:EarningsPerSharePolicyTextBlock>

<us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000471">

Income Taxes The Company is governed by the Income Tax Law and associated legislations of the PRC. The Company accounts for income taxes in accordance with FASB ASC 740 “Income Taxes” (formerly SFAS No. 109 Accounting for Income Taxes), which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. ASC 740 additionally requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets. Realization of deferred tax assets is dependent upon future earnings, if any, of which the timing and amount are uncertain. According to ASC 740, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.

</us-gaap:IncomeTaxPolicyTextBlock>

<us-gaap:IncomeTaxExaminationDescription contextRef="From2023-01-01to2023-12-31" id="Fact000473"> greater than 50% likelihood </us-gaap:IncomeTaxExaminationDescription>

<us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000475">

Translation of Foreign Currencies For subsidiaries where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders’ equity, into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive loss as a component of shareholders’ equity in the consolidated balance sheet. <p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zET1Grth5vQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> SCHEDULE OF TRANSLATION OF FOREIGN CURRENCIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zR1FZ99qkO36" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_ztxjcTw7OVZd" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_hus-gaap--AwardTypeAxis__custom--YearEndedRMBUSDExchangeRateMember_zJWPC427ULBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Year ended RMB: USD Exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.1412</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.1450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_hus-gaap--AwardTypeAxis__custom--AverageYearlyRMBUSDExchangeRateMember_znG8eMu6rZn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Average yearly RMB: USD Exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1485</td><td style="text-align: left"> </td></tr> </table> The RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions. No representation is made that the RMB amounts could have been, or could be, converted into USD at the rates used in translation. For the years ended December 31, 2023 and 2022 foreign currency translation adjustments of $13,544 and $44,546 respectively, have been reported as other comprehensive loss in the consolidated financial statements.

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>

<us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000477">

<p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zET1Grth5vQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> SCHEDULE OF TRANSLATION OF FOREIGN CURRENCIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zR1FZ99qkO36" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_ztxjcTw7OVZd" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_hus-gaap--AwardTypeAxis__custom--YearEndedRMBUSDExchangeRateMember_zJWPC427ULBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Year ended RMB: USD Exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.1412</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.1450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_hus-gaap--AwardTypeAxis__custom--AverageYearlyRMBUSDExchangeRateMember_znG8eMu6rZn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Average yearly RMB: USD Exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1485</td><td style="text-align: left"> </td></tr> </table>

</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>

<us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2023-12-31_custom_YearEndedRMBUSDExchangeRateMember" decimals="INF" id="Fact000479" unitRef="Pure"> 0.1412 </us-gaap:ForeignCurrencyExchangeRateTranslation1>

<us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2022-12-31_custom_YearEndedRMBUSDExchangeRateMember" decimals="INF" id="Fact000480" unitRef="Pure"> 0.1450 </us-gaap:ForeignCurrencyExchangeRateTranslation1>

<us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2023-12-31_custom_AverageYearlyRMBUSDExchangeRateMember" decimals="INF" id="Fact000482" unitRef="Pure"> 0.1423 </us-gaap:ForeignCurrencyExchangeRateTranslation1>

<us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2022-12-31_custom_AverageYearlyRMBUSDExchangeRateMember" decimals="INF" id="Fact000483" unitRef="Pure"> 0.1485 </us-gaap:ForeignCurrencyExchangeRateTranslation1>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000485" unitRef="USD"> 13544 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>

<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000487" unitRef="USD"> 44546 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>

<us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000489">

Other Comprehensive Income Other comprehensive income is defined as the change in equity during the period from transactions and other events, excluding the changes resulting from investments by owners and distributions to owners. Other comprehensive income is not included in the computation of income tax expense or benefit. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>

<us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000491">

Segment Information The Company follows FASB ASC 280-Segment Reporting, which requires that companies disclose segment data based on how management makes decision about allocating resources to segments and evaluating their performance. For the year ended December 31, 2023, the Company is operating in one reportable business segment, Healthcare. For the year ended December 31, 2022, management has determined that the Company is operating in two reportable business segments, Healthcare and Motor Controller. The Company’s reportable segments are strategic business units that offer different products. They are managed separately based on the fundamental differences in their operations.

</us-gaap:SegmentReportingPolicyPolicyTextBlock>

<us-gaap:NumberOfReportableSegments contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000493" unitRef="Segments"> 1 </us-gaap:NumberOfReportableSegments>

<us-gaap:NumberOfReportableSegments contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000495" unitRef="Segments"> 2 </us-gaap:NumberOfReportableSegments>

<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000497">

Recent Accounting Pronouncements The Company is an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. As a result, the Group’s operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards. In November 2023, the Financial Accounting Standards Board (“FASB”) issued a new standard to improve reportable segment disclosures. The guidance expands the disclosures required for reportable segments in our annual and interim consolidated financial statements, primarily through enhanced disclosures about significant segment expenses. The standard will be effective for us beginning with our annual reporting for fiscal year 2025 and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of this standard on our segment disclosures. In December 2023, the FASB issued a new standard to improve income tax disclosures. The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The standard will be effective for us beginning with our annual reporting for fiscal year 2026, with early adoption permitted. We are currently evaluating the impact of this standard on our income tax disclosures. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>

<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000499">

NOTE 2 – GOING CONCERN As of December 31, 2023, the Company has continuingly generated revenues from its business operations and has incurred an accumulated deficit of $1,064,348 and a negative working capital of $543,964. The Company will require additional funding to meet its ongoing obligations and to fund anticipated operating losses. The ability of the Company to continue as a going concern is dependent on raising capital to fund its business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern from a period of one year from the issuance of these financial statements. The Company intends to continue to fund its business by way of private placements and financing supports from related parties as may be required. As of December 31, 2023, the Company has raised $107,200 from sale of 518,000 shares of common stock. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>

<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-12-31" decimals="0" id="Fact000500" unitRef="USD"> -1064348 </us-gaap:RetainedEarningsAccumulatedDeficit>

<TANAF:WorkingCapital contextRef="AsOf2023-12-31" decimals="0" id="Fact000501" unitRef="USD"> -543964 </TANAF:WorkingCapital>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" decimals="0" id="Fact000502" unitRef="USD"> 107200 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" decimals="INF" id="Fact000503" unitRef="Shares"> 518000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>

<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000505">

NOTE 3 – EQUIPMENT, NET On December 29, 2022, the Company disposed all of its equipment for $163 and reported a loss from the disposal of $978. As of December 31, 2023 and 2022, the ending balance of equipment was $0. Depreciation expenses for the years ended December 31, 2023 and 2022 were $0 and $1,009, respectively. There is no any impairment situation for the years ended December 31, 2023 and 2022, respectively.

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>

<us-gaap:PropertyPlantAndEquipmentDisposals contextRef="From2022-12-292022-12-29" decimals="0" id="Fact000506" unitRef="USD"> 163 </us-gaap:PropertyPlantAndEquipmentDisposals>

<us-gaap:GainLossOnDispositionOfAssets contextRef="From2022-12-292022-12-29" decimals="0" id="Fact000507" unitRef="USD"> -978 </us-gaap:GainLossOnDispositionOfAssets>

<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31" decimals="0" id="Fact000508" unitRef="USD"> 0 </us-gaap:PropertyPlantAndEquipmentGross>

<us-gaap:Depreciation contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000510" unitRef="USD"> 0 </us-gaap:Depreciation>

<us-gaap:Depreciation contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000512" unitRef="USD"> 1009 </us-gaap:Depreciation>

<us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000514">

NOTE 4 – LEASES The Company’s lease portfolio primarily consists of an office lease. The lease had a term from April 17, 2021 to April 16, 2024. On October 13, 2022, the Company early terminated the lease. Instead, the Company relocated with a 12-month new lease, which the Company elected not to recognize a right-of-use asset and lease liability requirement to this lease, because it has a lease term of 12 months or less. The Company recognized the lease payments in profit or loss on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred. As of December 31, 2023 and 2022, the Company reported no right-of-use assets and lease liabilities. The following table summarizes the lease costs recognized in the consolidated statements of earnings: SCHEDULE OF LEASE COST <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20231231_zZiaVpKaSRD6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zvPWiaxl6ALi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_maLCzsI5_zAcmJ3fWYGEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,461</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ShortTermLeaseCost_maLCzsI5_z0i6Ey3GGaUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term lease cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,005</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--VariableLeaseCost_maLCzsI5_zqoeDnOWtKa3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Variable lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LeaseCost_iT_mtLCzsI5_zOqVdv9tyfDf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,686</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,466</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table presents supplementary cash flow information regarding the company’s leases: SCHEDULE OF SUPPLEMENTARY CASH FLOW INFORMATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zuIbKJktYet6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231_z9f2e4U802Nf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_iN_di_zrTZvHv1X9P3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 2.5pt">Operating cash flows from operating activities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">-</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">4,461</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_z3ntdW1UAWn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use assets obtained in exchange for new operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases_zhYynHqxru2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Reduction of right-of-use assets and lease liabilities for cancelation of old leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,048</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

</us-gaap:LeasesOfLesseeDisclosureTextBlock>

<us-gaap:LesseeOperatingLeaseDescription contextRef="From2023-01-01to2023-12-31" id="Fact000515"> April 17, 2021 to April 16, 2024 </us-gaap:LesseeOperatingLeaseDescription>

<us-gaap:LeaseCostTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000517">

The following table summarizes the lease costs recognized in the consolidated statements of earnings: SCHEDULE OF LEASE COST <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20231231_zZiaVpKaSRD6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zvPWiaxl6ALi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_maLCzsI5_zAcmJ3fWYGEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,461</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ShortTermLeaseCost_maLCzsI5_z0i6Ey3GGaUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term lease cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,005</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--VariableLeaseCost_maLCzsI5_zqoeDnOWtKa3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Variable lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LeaseCost_iT_mtLCzsI5_zOqVdv9tyfDf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,686</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,466</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

</us-gaap:LeaseCostTableTextBlock>

<us-gaap:OperatingLeaseCost contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000520" unitRef="USD"> 4461 </us-gaap:OperatingLeaseCost>

<us-gaap:ShortTermLeaseCost contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000522" unitRef="USD"> 7686 </us-gaap:ShortTermLeaseCost>

<us-gaap:ShortTermLeaseCost contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000523" unitRef="USD"> 2005 </us-gaap:ShortTermLeaseCost>

<us-gaap:LeaseCost contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000528" unitRef="USD"> 7686 </us-gaap:LeaseCost>

<us-gaap:LeaseCost contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000529" unitRef="USD"> 6466 </us-gaap:LeaseCost>

<us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000531">

The following table presents supplementary cash flow information regarding the company’s leases: SCHEDULE OF SUPPLEMENTARY CASH FLOW INFORMATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zuIbKJktYet6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231_z9f2e4U802Nf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_iN_di_zrTZvHv1X9P3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 2.5pt">Operating cash flows from operating activities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">-</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">4,461</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_z3ntdW1UAWn5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use assets obtained in exchange for new operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases_zhYynHqxru2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Reduction of right-of-use assets and lease liabilities for cancelation of old leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,048</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>

<us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000534" unitRef="USD"> -4461 </us-gaap:IncreaseDecreaseInOperatingLeaseLiability>

<TANAF:ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000540" unitRef="USD"> 9048 </TANAF:ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases>

<us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000542">

NOTE 5 – LOAN PAYABLES On November 20, 2021, the Company entered into a loan agreement of $<span id="xdx_90B_eus-gaap--LoansPayable_iI_c20211120__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__dei--LegalEntityAxis__custom--ShenzhenShihongEducationAndCultureLtdMember_zORceT70temk" title="Loans payable">108,500 with Shenzhen Shihong Education and Culture Ltd. The loan is due on November 22, 2022 without interest charge if the loan is repaid upon due. If the loan was not fully repaid on or before November 22, 2022, the Company will be charge 0.03% interest rate per day. The Company repaid the loan in full on May 20, 2022. As of December 31, 2023 and 2022, the ending balance of loan payables was $0 and $0, respectively.

</us-gaap:DebtDisclosureTextBlock>

<us-gaap:LoansPayable contextRef="AsOf2021-11-20_custom_LoanAgreementMember_custom_ShenzhenShihongEducationAndCultureLtdMember" decimals="0" id="Fact000544" unitRef="USD"> 108500 </us-gaap:LoansPayable>

<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2022-11-22" decimals="INF" id="Fact000546" unitRef="Pure"> 0.0003 </us-gaap:DebtInstrumentInterestRateStatedPercentage>

<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000552">

NOTE 6 – RELATED PARTY TRANSACTIONS Due to related parties On July 15, 2019, the Company entered into a loan agreement of $459,315 with one of its related parties, Liaoning Xinjian Linguo Yitang Health Management Ltd., without interest charge and collateral. The loan is due on demand. The Company’s CEO, Mr. Heng Fei Yang, is the actual controlling owner of Liaoning Xinjian Linguo Yitang Health Management Ltd. The loan had been fully repaid during the year ended December 31, 2022. During the years ended December 31, 2023 and 2022, the Company repaid $0 and $185,668, respectively. As of December 31, 2023 and 2022, the outstanding balance of the loan was $0. On April 15, 2021, the Company entered into a loan agreement of $293,493 with one of its related parties, Mr. Heng Fei Yang, without interest charge and collateral. The loan is due on demand. Mr. Heng Fei Yang is the Company’s CEO. The loan was repaid in full during the second quarter of 2022. During the years ended December 31, 2023 and 2022, the Company borrowed an aggregate of $130,943 and $121,501 proceeds from Mr. Yang, and repaid $78,281 and $355,517, respectively. As of December 31, 2023 and 2022, the outstanding balance of the loan was $97,138 and $46,098, respectively. On August 20, 2022, the Company entered into a 12-month loan agreement of $178,241 with one of its related parties, Mr. Jinhua Xu, without interest charge and collateral. The loan was fully repaid during the year ended December 31, 2023. During the years ended December 31, 2023 and 2022, the Company repaid $170,795 and $0, respectively. As of December 31, 2023 and 2022, the outstanding balance of the loan was $0 and $173,956, respectively. On September 23, 2022 and October 14, 2022, the Company entered into two 3-month loan agreements in total of $12,625 with one of its related parties, Ms. Xiaoyan Yuan, without interest charge and collateral. The loans had been repaid in full on October 28, 2022. As of December 31, 2023 and 2022, there was no outstanding balance. Advances from related parties On April 18, 2023, the Company entered into a sale agreement with Suzhou Aixi Health Technology Co., Ltd. (“Aixi”) to sell 100 sets of granphene based sauna rooms for approximately $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230418__20230418__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SuzhouAxixiHealthTechnologyCoLtdMember_zIfEPXea75tk" title="Sale value">253,000. The Company collected $155,135 as advances from Aixi as of December 31, 2023. On June 20, 2023, the Company entered into a sale agreement with Shanghai Shengji Trade Co., Ltd. (“Shengji”) to sell 100 sets of granphene based sauna rooms for approximately $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230619__20230620__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiShengjiTradingCoLtdMember_zuvwS9cE8mv7" title="Sale value">253,000. The Company collected $211,784 as advances from Shengji as of December 31, 2023. Sales with a related party During the years ended December 31, 2023 and 2022, the Company sold healthcare products of $64,035 and $32,342 to one of its related parties, Suzhou Xinjianlin Health Management Co., Ltd. (“Xinjianlin “). As of December 31, 2023 and 2022, the balance of advances from Xinjianlin was $<span id="xdx_90B_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SuzhouXinjianlinHealthManagementCoLtdMember_zCAIzbfmAxr4" title="Advances from related party customers">0 and $<span id="xdx_90E_eus-gaap--OtherReceivables_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SuzhouXinjianlinHealthManagementCoLtdMember_ztNTfPzzYzS6" title="Advances from related party customers">1,703, respectively.

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>

<us-gaap:OtherLiabilities contextRef="AsOf2019-07-15_custom_LiaoningXinjianLinguoYitangHealthManagementLtdMember" decimals="0" id="Fact000553" unitRef="USD"> 459315 </us-gaap:OtherLiabilities>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2023-01-012023-12-31_custom_LiaoningXinjianLinguoYitangHealthManagementLtdMember" decimals="0" id="Fact000554" unitRef="USD"> 0 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2022-01-012022-12-31_custom_LiaoningXinjianLinguoYitangHealthManagementLtdMember" decimals="0" id="Fact000555" unitRef="USD"> 185668 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:OtherLiabilities contextRef="AsOf2022-12-31_custom_LiaoningXinjianLinguoYitangHealthManagementLtdMember" decimals="0" id="Fact000556" unitRef="USD"> 0 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2021-04-15_custom_MrHengFeiYangMember" decimals="0" id="Fact000557" unitRef="USD"> 293493 </us-gaap:OtherLiabilities>

<us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2023-01-012023-12-31_custom_MrHengFeiYangMember" decimals="0" id="Fact000558" unitRef="USD"> 130943 </us-gaap:ProceedsFromRelatedPartyDebt>

<us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2022-01-012022-12-31_custom_MrHengFeiYangMember" decimals="0" id="Fact000559" unitRef="USD"> 121501 </us-gaap:ProceedsFromRelatedPartyDebt>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2023-01-012023-12-31_custom_MrHengFeiYangMember" decimals="0" id="Fact000560" unitRef="USD"> 78281 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2022-01-012022-12-31_custom_MrHengFeiYangMember" decimals="0" id="Fact000561" unitRef="USD"> 355517 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:OtherLiabilities contextRef="AsOf2023-12-31_custom_MrHengFeiYangMember" decimals="0" id="Fact000562" unitRef="USD"> 97138 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2022-12-31_custom_MrHengFeiYangMember" decimals="0" id="Fact000563" unitRef="USD"> 46098 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2022-08-20_custom_MrJinhuaXuMember" decimals="0" id="Fact000564" unitRef="USD"> 178241 </us-gaap:OtherLiabilities>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2023-01-012023-12-31_custom_MrJinhuaXuMember" decimals="0" id="Fact000565" unitRef="USD"> 170795 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2022-01-012022-12-31_custom_MrJinhuaXuMember" decimals="0" id="Fact000566" unitRef="USD"> 0 </us-gaap:RepaymentsOfRelatedPartyDebt>

<us-gaap:OtherLiabilities contextRef="AsOf2023-12-31_custom_MrJinhuaXuMember" decimals="0" id="Fact000567" unitRef="USD"> 0 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2022-12-31_custom_MrJinhuaXuMember" decimals="0" id="Fact000568" unitRef="USD"> 173956 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2022-09-23_custom_MsXiaoyanYuanMember" decimals="0" id="Fact000570" unitRef="USD"> 12625 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2022-10-14_custom_MsXiaoyanYuanMember" decimals="0" id="Fact000572" unitRef="USD"> 12625 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2023-12-31_custom_MsXiaoyanYuanMember" decimals="0" id="Fact000574" unitRef="USD"> 0 </us-gaap:OtherLiabilities>

<us-gaap:OtherLiabilities contextRef="AsOf2022-12-31_custom_MsXiaoyanYuanMember" decimals="0" id="Fact000576" unitRef="USD"> 0 </us-gaap:OtherLiabilities>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-04-182023-04-18_custom_SuzhouAxixiHealthTechnologyCoLtdMember" decimals="0" id="Fact000578" unitRef="USD"> 253000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-12-31_custom_SuzhouAxixiHealthTechnologyCoLtdMember" decimals="0" id="Fact000580" unitRef="USD"> 155135 </us-gaap:PrepaidExpenseCurrent>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-06-192023-06-20_custom_ShanghaiShengjiTradingCoLtdMember" decimals="0" id="Fact000582" unitRef="USD"> 253000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-12-31_custom_ShanghaiShengjiTradingCoLtdMember" decimals="0" id="Fact000584" unitRef="USD"> 211784 </us-gaap:PrepaidExpenseCurrent>

<us-gaap:Revenues contextRef="From2023-01-012023-12-31_custom_SuzhouXinjianlinHealthManagementCoLtdMember" decimals="0" id="Fact000586" unitRef="USD"> 64035 </us-gaap:Revenues>

<us-gaap:Revenues contextRef="From2022-01-012022-12-31_custom_SuzhouXinjianlinHealthManagementCoLtdMember" decimals="0" id="Fact000588" unitRef="USD"> 32342 </us-gaap:Revenues>

<us-gaap:OtherReceivables contextRef="AsOf2023-12-31_custom_SuzhouXinjianlinHealthManagementCoLtdMember" decimals="0" id="Fact000590" unitRef="USD"> 0 </us-gaap:OtherReceivables>

<us-gaap:OtherReceivables contextRef="AsOf2022-12-31_custom_SuzhouXinjianlinHealthManagementCoLtdMember" decimals="0" id="Fact000592" unitRef="USD"> 1703 </us-gaap:OtherReceivables>

<us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000594">

NOTE 7 – OTHER PAYABLES As of December 31, 2023 and 2022, the Company reported $110,298 and $124,986 as its other payables, respectively. The other payables mainly consist of payables for professional services, including audit, legal, and financial statement filing services.

</us-gaap:OtherLiabilitiesDisclosureTextBlock>

<us-gaap:OtherNotesPayableCurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000596" unitRef="USD"> 110298 </us-gaap:OtherNotesPayableCurrent>

<us-gaap:OtherNotesPayableCurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000598" unitRef="USD"> 124986 </us-gaap:OtherNotesPayableCurrent>

<TANAF:SharesToBeIssuedDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000600">

NOTE 8 – SHARES TO BE ISSUED On October 26, 2023, the Company sold 500,000 shares at $0.2 per share to Mr. Gang Wang for $100,000. These shares were issued at January 5, 2024. On December 25, 2023, the Company sold 18,000 shares at $0.4 per share to Mr. Lihong Zou for $7,200. These shares were issued at January 5, 2024.

</TANAF:SharesToBeIssuedDisclosureTextBlock>

<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2023-10-262023-10-26_custom_MrGangWangMember" decimals="INF" id="Fact000602" unitRef="Shares"> 500000 </us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>

<us-gaap:SaleOfStockPricePerShare contextRef="AsOf2023-10-26_custom_MrGangWangMember" decimals="INF" id="Fact000604" unitRef="USDPShares"> 0.2 </us-gaap:SaleOfStockPricePerShare>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-10-262023-10-26_custom_MrGangWangMember" decimals="0" id="Fact000606" unitRef="USD"> 100000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2023-12-252023-12-25_custom_MrLihongZouMember" decimals="INF" id="Fact000608" unitRef="Shares"> 18000 </us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>

<us-gaap:SaleOfStockPricePerShare contextRef="AsOf2023-12-25_custom_MrLihongZouMember" decimals="INF" id="Fact000610" unitRef="USDPShares"> 0.4 </us-gaap:SaleOfStockPricePerShare>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-12-252023-12-25_custom_MrLihongZouMember" decimals="0" id="Fact000612" unitRef="USD"> 7200 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000614">

NOTE 9 – EQUITY The Company is authorized to issue 100,000,000 shares of common stock without par value. As of December 31, 2023 and 2022, it had 45,000,000 shares outstanding. On July 13, 2022, the Company declared a reverse stock split to convert its outstanding common stock from 100,000,000 shares to 40,000,000 shares. On August 22, 2022, the Company issued 5 million shares to 66 individuals for RMB 3,400,700 or approximately $500,000. The relevant subscription receivable has been collected in May and June 2022.

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>

<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-12-31" decimals="INF" id="Fact000616" unitRef="Shares"> 100000000 </us-gaap:CommonStockSharesAuthorized>

<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-12-31" decimals="INF" id="Fact000618" unitRef="Shares"> 45000000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" id="Fact000620" unitRef="Shares"> 45000000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-07-12" decimals="INF" id="Fact000622" unitRef="Shares"> 100000000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-07-13" decimals="INF" id="Fact000624" unitRef="Shares"> 40000000 </us-gaap:CommonStockSharesOutstanding>

<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-08-222022-08-22_custom_SixtySixIndividualMember" decimals="-6" id="Fact000626" unitRef="Shares"> 5000000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-08-222022-08-22_custom_SixtySixIndividualMember" decimals="0" id="Fact000628" unitRef="RMB"> 3400700 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-08-222022-08-22_custom_SixtySixIndividualMember" decimals="0" id="Fact000630" unitRef="USD"> 500000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>

<us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000632">

NOTE 10 – TAXES Income Taxes British Virgin Islands (“BVI”) Tian’an is registered in BVI and are not subject to tax on income or capital gain. In addition, payments of dividends by Tian’an to their shareholders are not subject to withholding tax in the BVI. Hong Kong The Company’s subsidiary, Yunke, is incorporated in Hong Kong and have no operating profit or tax liabilities during the period. Yunke is subject to tax at 16.5% on the assessable profits arising in or derived from Hong Kong. The PRC The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%. The reconciliation of income tax rate to the effective income tax rate for the years ended December 31, 2023 and 2022 from our continuing operation is as follows: SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20231231_zPxCpoyWd8h1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zDi8j4xZSZM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--ForeignIncomeTaxExpenseBenefitContinuingOperations_zQKLGYip78ng" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Loss before income taxes from operations in the PRC</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(250,009</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(280,517</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUBe9C67qiV4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzoXt_z1owtyhNMGq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense at statutory rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,502</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(70,129</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_maITEBzoXt_zrQ84waSTrY7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax effect of non-deductible items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzoXt_zG8IlPmH4yy1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance of deferred tax assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,502</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">70,129</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzoXt_zFubqx4QcLj7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Management believes that it is more likely than not that the deferred tax assets will not be fully realizable in the future. Accordingly, the Company provided for a full valuation allowance against its deferred tax assets of $62,502 and $70,129 for the years ended December 31, 2023 and 2022, primarily relating to net operating loss carryforwards from the local tax regime. Value-Added Tax and Other Withholding and Other Levies The Company’s products are sold in the PRC and are subject to VAT on the gross sales price. The VAT rates range up to 13%, depending on the type of products sold. The VAT may be offset by VAT paid by the Company for raw materials and other materials included in the cost of producing or acquiring its finished products. The Company records a VAT payable net of payments if the VAT payable on the gross sales is larger than VAT paid by the Company on purchase of materials or finished goods: otherwise, the Company records a VAT deductible in the accompanying financial statements net of any VAT payable at the end of reporting periods. As of December 31, 2023 and 2022, the Company recorded VAT payable (credit) of $(1,500) and $1,570, respectively. The Company is also subject to other levies such as stamp tax, unban construction tax, additional education tax which are charged by local governments. The rates of such levies are small and vary among the different jurisdictions in which the Company does business. The Company also acts as the personal income tax withholding agent for the salaries paid its employees. As of December 31, 2023 and 2022, the Company recorded other levies and withholding $0, respectively.

</us-gaap:IncomeTaxDisclosureTextBlock>

<us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000634" unitRef="Pure"> 0.165 </us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>

<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000636" unitRef="Pure"> 0.25 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>

<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000638">

SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20231231_zPxCpoyWd8h1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zDi8j4xZSZM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--ForeignIncomeTaxExpenseBenefitContinuingOperations_zQKLGYip78ng" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Loss before income taxes from operations in the PRC</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(250,009</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(280,517</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zUBe9C67qiV4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzoXt_z1owtyhNMGq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense at statutory rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,502</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(70,129</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_maITEBzoXt_zrQ84waSTrY7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax effect of non-deductible items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzoXt_zG8IlPmH4yy1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance of deferred tax assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,502</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">70,129</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzoXt_zFubqx4QcLj7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>

<us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000640" unitRef="USD"> -250009 </us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>

<us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000641" unitRef="USD"> -280517 </us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>

<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000643" unitRef="Pure"> 0.25 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>

<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000644" unitRef="Pure"> 0.25 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>

<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000646" unitRef="USD"> -62502 </us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>

<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000647" unitRef="USD"> -70129 </us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>

<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000652" unitRef="USD"> 62502 </us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>

<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000653" unitRef="USD"> 70129 </us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>

<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000658" unitRef="USD"> 62502 </us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>

<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000660" unitRef="USD"> 70129 </us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>

<TANAF:ValueAddedTaxPercentage contextRef="AsOf2023-12-31" decimals="INF" id="Fact000662" unitRef="Pure"> 0.13 </TANAF:ValueAddedTaxPercentage>

<us-gaap:ValueAddedTaxReceivable contextRef="AsOf2023-12-31" decimals="0" id="Fact000664" unitRef="USD"> 1500 </us-gaap:ValueAddedTaxReceivable>

<us-gaap:ValueAddedTaxReceivable contextRef="AsOf2022-12-31" decimals="0" id="Fact000666" unitRef="USD"> 1570 </us-gaap:ValueAddedTaxReceivable>

<TANAF:IncomeTaxExpensesRelatedToOtherLeviesAndWithholding contextRef="AsOf2023-12-31" decimals="0" id="Fact000668" unitRef="USD"> 0 </TANAF:IncomeTaxExpensesRelatedToOtherLeviesAndWithholding>

<TANAF:IncomeTaxExpensesRelatedToOtherLeviesAndWithholding contextRef="AsOf2022-12-31" decimals="0" id="Fact000670" unitRef="USD"> 0 </TANAF:IncomeTaxExpensesRelatedToOtherLeviesAndWithholding>

<us-gaap:EarningsPerShareTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000672">

NOTE 11 – NET LOSS PER SHARE Basic net loss per share is computed using the weighted average number of common shares outstanding during the year. The dilutive effect of potential common shares outstanding is included in diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2023 and 2022: SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20231231_zkYNFr5Lykxb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zGVXHeztRER2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zv6Xx5kY0JV4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss attributable to common shareholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(250,009</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(280,517</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Weighted average common shares outstanding – Basic and diluted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,821,918</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss per shares – basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

</us-gaap:EarningsPerShareTextBlock>

<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000674">

SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20231231_zkYNFr5Lykxb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zGVXHeztRER2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zv6Xx5kY0JV4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss attributable to common shareholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(250,009</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(280,517</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Weighted average common shares outstanding – Basic and diluted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,821,918</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss per shares – basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>

<us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000676" unitRef="USD"> -250009 </us-gaap:NetIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000677" unitRef="USD"> -280517 </us-gaap:NetIncomeLoss>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000679" unitRef="Shares"> 45000000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000681" unitRef="Shares"> 45000000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000683" unitRef="Shares"> 41821918 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000685" unitRef="Shares"> 41821918 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

<us-gaap:EarningsPerShareBasic contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000687" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>

<us-gaap:EarningsPerShareDiluted contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000689" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>

<us-gaap:EarningsPerShareBasic contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000691" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>

<us-gaap:EarningsPerShareDiluted contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000693" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>

<us-gaap:StatutoryAccountingPracticesDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000695">

NOTE 12 – STATUTORY RESERVES Under the laws of the PRC the Company’s subsidiaries are required to make appropriations to the statutory reserve based on after-tax net earnings and determined in accordance with generally accepted accounting principles of the People’s Republic of China (the “PRC GAAP”). Appropriation to the statutory reserve should be at least 10% of the after-tax net income until the reserve is equal to 50% of the registered capital. The statutory reserve is established for the purpose of providing employee facilities and other collective benefits to the employees and is non-distributable other than in liquidation. The reserves amounted to $0 and $0 as of December 31, 2023 and 2022.

</us-gaap:StatutoryAccountingPracticesDisclosureTextBlock>

<us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusVariations contextRef="From2023-01-01to2023-12-31" id="Fact000697"> Appropriation to the statutory reserve should be at least 10% of the after-tax net income until the reserve is equal to 50% of the registered capital. </us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusVariations>

<TANAF:StatutoryReserves contextRef="AsOf2023-12-31" decimals="0" id="Fact000699" unitRef="USD"> 0 </TANAF:StatutoryReserves>

<TANAF:StatutoryReserves contextRef="AsOf2022-12-31" decimals="0" id="Fact000701" unitRef="USD"> 0 </TANAF:StatutoryReserves>

<us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000703">

NOTE 13 – SEGMENTS In 2022, the Company operated in two reportable business segments, Healthcare and Motor Controller. In 2023, the Company had one reportable business segment, Healthcare. The Company’s reportable segments are strategic business units that offer different products. They are managed separately based on the fundamental differences in their operations. Information with respect to these reportable business segments is as the following: SCHEDULE OF REPORTABLE BUSINESS SEGMENTS For the year ended December 31, 2023 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zDQw3kRXH5l7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--CostOfRevenue_z4E3zJoRtZW5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--GrossProfit_zzHEvy6G4e28" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross profit</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_485_eus-gaap--OperatingIncomeLoss_zECkdajvSRM6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Loss from operations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--DepreciationDepletionAndAmortization_zrtsU1qNpe6f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Depreciation and amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_411_20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zn4PqTEi2K4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Healthcare</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">246,619</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">179,938</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">66,681</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(249,325</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zdeCkt0voeD3" style="width: 6%; text-align: right" title="Assets">177,233</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_414_20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zHzP5PCQgLS8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor controller</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Assets_iI_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zgHYyGzpjp1b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Assets">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_41C_20230101__20231231_z9PJDh5cyvs6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Segment Totals</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">246,619</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">179,938</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,681</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(249,325</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_c20231231_zW1GqfrEYIH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">177,233</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Loss, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--OtherNonoperatingIncomeLoss_c20230101__20231231_zi44e0BMc7Ih" style="text-align: right" title="Other loss, net">(684</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax benefits</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20231231_z0iiy20tI2wc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Income tax benefits">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unallocated Assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--UnallocatedAssets_iI_c20231231_znWnkkJbzSNj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unallocated assets">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20230101__20231231_zLLQo7oQ15Aa" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(250,009</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20231231_zQa92zTOXICb" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">177,233</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> For the year ended December 31, 2022 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zgeZGjncR3i1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--CostOfRevenue_zNWDMBCfDNbh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--GrossProfit_zrHGtlhKz6zk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross profit</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_485_eus-gaap--OperatingIncomeLoss_zvzNua8WbBLj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Loss from operations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--DepreciationDepletionAndAmortization_ziJ4oEIrtYw3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Depreciation and amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_410_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zXTK9tmAkNJh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Healthcare</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">152,432</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">111,683</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">40,749</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(141,444</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zcxcYZBhzyqe" style="width: 6%; text-align: right" title="Assets">59,720</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_41B_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zemHmk84CkEi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor controller</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">43,301</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,222</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,079</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(137,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,470</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--Assets_iI_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zMnI77Q299ej" style="border-bottom: Black 1.5pt solid; text-align: right" title="Assets">14,982</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_413_20220101__20221231_zh4BS5gMA69i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Segment Totals</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">195,733</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">142,905</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">52,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(278,725</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--Assets_iI_c20221231_zqVqV2S2BSZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">74,702</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Loss, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--OtherNonoperatingIncomeLoss_c20220101__20221231_zi95pwiNhekf" style="text-align: right" title="Other loss, net">(1,792</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax benefits</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zEUYnzVqxDhe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Income tax benefits">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unallocated Assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--UnallocatedAssets_iI_c20221231_zcDJBVdShn8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unallocated assets">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20221231_z6nzXIUbk4J" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(280,517</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20221231_zkLuYJXLXw3d" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">74,702</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

</us-gaap:SegmentReportingDisclosureTextBlock>

<us-gaap:NumberOfReportableSegments contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000705" unitRef="Segments"> 2 </us-gaap:NumberOfReportableSegments>

<us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000707">

SCHEDULE OF REPORTABLE BUSINESS SEGMENTS For the year ended December 31, 2023 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zDQw3kRXH5l7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--CostOfRevenue_z4E3zJoRtZW5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--GrossProfit_zzHEvy6G4e28" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross profit</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_485_eus-gaap--OperatingIncomeLoss_zECkdajvSRM6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Loss from operations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--DepreciationDepletionAndAmortization_zrtsU1qNpe6f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Depreciation and amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_411_20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zn4PqTEi2K4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Healthcare</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">246,619</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">179,938</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">66,681</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(249,325</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zdeCkt0voeD3" style="width: 6%; text-align: right" title="Assets">177,233</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_414_20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zHzP5PCQgLS8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor controller</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Assets_iI_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zgHYyGzpjp1b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Assets">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_41C_20230101__20231231_z9PJDh5cyvs6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Segment Totals</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">246,619</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">179,938</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,681</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(249,325</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_c20231231_zW1GqfrEYIH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">177,233</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Loss, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--OtherNonoperatingIncomeLoss_c20230101__20231231_zi44e0BMc7Ih" style="text-align: right" title="Other loss, net">(684</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax benefits</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20231231_z0iiy20tI2wc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Income tax benefits">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unallocated Assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--UnallocatedAssets_iI_c20231231_znWnkkJbzSNj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unallocated assets">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20230101__20231231_zLLQo7oQ15Aa" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(250,009</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20231231_zQa92zTOXICb" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">177,233</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> For the year ended December 31, 2022 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zgeZGjncR3i1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--CostOfRevenue_zNWDMBCfDNbh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost of revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48B_eus-gaap--GrossProfit_zrHGtlhKz6zk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross profit</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_485_eus-gaap--OperatingIncomeLoss_zvzNua8WbBLj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Loss from operations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--DepreciationDepletionAndAmortization_ziJ4oEIrtYw3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Depreciation and amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_410_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zXTK9tmAkNJh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Healthcare</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">152,432</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">111,683</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">40,749</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(141,444</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthCareSegmentMember_zcxcYZBhzyqe" style="width: 6%; text-align: right" title="Assets">59,720</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_41B_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zemHmk84CkEi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor controller</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">43,301</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,222</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,079</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(137,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,470</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--Assets_iI_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--MotorControllerMember_zMnI77Q299ej" style="border-bottom: Black 1.5pt solid; text-align: right" title="Assets">14,982</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_413_20220101__20221231_zh4BS5gMA69i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Segment Totals</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">195,733</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">142,905</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">52,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(278,725</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--Assets_iI_c20221231_zqVqV2S2BSZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">74,702</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Loss, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--OtherNonoperatingIncomeLoss_c20220101__20221231_zi95pwiNhekf" style="text-align: right" title="Other loss, net">(1,792</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax benefits</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zEUYnzVqxDhe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Income tax benefits">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unallocated Assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--UnallocatedAssets_iI_c20221231_zcDJBVdShn8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unallocated assets">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20221231_z6nzXIUbk4J" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(280,517</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20221231_zkLuYJXLXw3d" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">74,702</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-012023-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000708" unitRef="USD"> 246619 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:CostOfRevenue contextRef="From2023-01-012023-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000709" unitRef="USD"> 179938 </us-gaap:CostOfRevenue>

<us-gaap:GrossProfit contextRef="From2023-01-012023-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000710" unitRef="USD"> 66681 </us-gaap:GrossProfit>

<us-gaap:OperatingIncomeLoss contextRef="From2023-01-012023-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000711" unitRef="USD"> -249325 </us-gaap:OperatingIncomeLoss>

<us-gaap:Assets contextRef="AsOf2023-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000714" unitRef="USD"> 177233 </us-gaap:Assets>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000722" unitRef="USD"> 246619 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:CostOfRevenue contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000723" unitRef="USD"> 179938 </us-gaap:CostOfRevenue>

<us-gaap:GrossProfit contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000724" unitRef="USD"> 66681 </us-gaap:GrossProfit>

<us-gaap:OperatingIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000725" unitRef="USD"> -249325 </us-gaap:OperatingIncomeLoss>

<us-gaap:Assets contextRef="AsOf2023-12-31" decimals="0" id="Fact000728" unitRef="USD"> 177233 </us-gaap:Assets>

<TANAF:OtherNonoperatingIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000730" unitRef="USD"> -684 </TANAF:OtherNonoperatingIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000736" unitRef="USD"> -250009 </us-gaap:NetIncomeLoss>

<us-gaap:Assets contextRef="AsOf2023-12-31" decimals="0" id="Fact000738" unitRef="USD"> 177233 </us-gaap:Assets>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000739" unitRef="USD"> 152432 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:CostOfRevenue contextRef="From2022-01-012022-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000740" unitRef="USD"> 111683 </us-gaap:CostOfRevenue>

<us-gaap:GrossProfit contextRef="From2022-01-012022-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000741" unitRef="USD"> 40749 </us-gaap:GrossProfit>

<us-gaap:OperatingIncomeLoss contextRef="From2022-01-012022-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000742" unitRef="USD"> -141444 </us-gaap:OperatingIncomeLoss>

<us-gaap:Assets contextRef="AsOf2022-12-31_custom_HealthCareSegmentMember" decimals="0" id="Fact000745" unitRef="USD"> 59720 </us-gaap:Assets>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-12-31_custom_MotorControllerMember" decimals="0" id="Fact000746" unitRef="USD"> 43301 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:CostOfRevenue contextRef="From2022-01-012022-12-31_custom_MotorControllerMember" decimals="0" id="Fact000747" unitRef="USD"> 31222 </us-gaap:CostOfRevenue>

<us-gaap:GrossProfit contextRef="From2022-01-012022-12-31_custom_MotorControllerMember" decimals="0" id="Fact000748" unitRef="USD"> 12079 </us-gaap:GrossProfit>

<us-gaap:OperatingIncomeLoss contextRef="From2022-01-012022-12-31_custom_MotorControllerMember" decimals="0" id="Fact000749" unitRef="USD"> -137281 </us-gaap:OperatingIncomeLoss>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2022-01-012022-12-31_custom_MotorControllerMember" decimals="0" id="Fact000750" unitRef="USD"> 5470 </us-gaap:DepreciationDepletionAndAmortization>

<us-gaap:Assets contextRef="AsOf2022-12-31_custom_MotorControllerMember" decimals="0" id="Fact000752" unitRef="USD"> 14982 </us-gaap:Assets>

<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000753" unitRef="USD"> 195733 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>

<us-gaap:CostOfRevenue contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000754" unitRef="USD"> 142905 </us-gaap:CostOfRevenue>

<us-gaap:GrossProfit contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000755" unitRef="USD"> 52828 </us-gaap:GrossProfit>

<us-gaap:OperatingIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000756" unitRef="USD"> -278725 </us-gaap:OperatingIncomeLoss>

<us-gaap:DepreciationDepletionAndAmortization contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000757" unitRef="USD"> 5470 </us-gaap:DepreciationDepletionAndAmortization>

<us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" id="Fact000759" unitRef="USD"> 74702 </us-gaap:Assets>

<TANAF:OtherNonoperatingIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000761" unitRef="USD"> -1792 </TANAF:OtherNonoperatingIncomeLoss>

<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000767" unitRef="USD"> -280517 </us-gaap:NetIncomeLoss>

<us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" id="Fact000769" unitRef="USD"> 74702 </us-gaap:Assets>

<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000771">

NOTE 13 – CONCENTRATIONS OF RISK The Company is exposed to the following concentrations of risk: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">a.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Credit risk and major customers</td></tr></table> Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. As of December 31, 2023 and 2022, 100% of the Company’s cash including cash on hand and deposits in accounts were maintained within the PRC where there is currently no rule or regulation in place for obligatory insurance to cover bank deposits in the event of a bank’s failure. However, the Company has not experienced any such losses and believes it is not exposed to any significant risks on its cash in bank accounts. The Company’s key customers are located in the PRC. The Company has not entered into long-term supply contracts with any of these major customers. During the years ended December 31, 2023 and 2022, the Company’s customers that accounted for 10% or more of the Company’s revenue were listed as follow: SCHEDULE OF CONCENTRATION OF RISK <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Customers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zS52U06TdjKj" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUDnKOnz1ty4" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Customers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerAMember_zKUcvj90jxw7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerBMember_zHVn42dvpcLj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerCMember_ztbsrjIDLjg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr> <tr id="xdx_404_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerDMember_zptkZmidm2jj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerEMember_zgpvvtUTzQxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerFMember_zmiQsLU6ZHDi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table> The suppliers accounted for 10% or more of the Company’s purchases during the years ended December 31, 2023 and 2022. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Suppliers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjSgmMLUMxT6" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFDuzcngqDsi" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Suppliers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--SuppliersAAMember_z7B2fiQLvf0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">AA</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">14</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">61</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--SuppliersBBMember_z6wVyC6vx5mg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">BB</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--SuppliersBBMember_zTOEexIEozqd" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Concentration risk percentage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">b.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Interest rate risk</td></tr></table> As the Company has no significant interest-bearing assets, the Company’s income and operating cash flows are substantially independent of changes in market interest rates. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">c.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Exchange rate risk</td></tr></table> The reporting currency of the Company is USD, to date the majority of the revenues and costs are denominated in RMB and a significant portion of the assets and liabilities are denominated in RMB. As a result, the Company is exposed to foreign exchange risk as its revenues and results of operations may be affected by fluctuations in the exchange rate between US$ and RMB. If RMB depreciates against US$, the value of RMB revenues and assets as expressed in USD financial statements will decline. The Company does not hold any derivative or other financial instruments that expose to substantial market risk. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">d.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Economic and political risks</td></tr></table> The Company’s operations are conducted in the PRC. Accordingly, the Company’s business, financial condition and results of operation may be influenced by the political, economic and legal environment in the PRC, and by the general state of the PRC economy. The outbreak of COVID-19 pandemic has expanded all over the world since the beginning of 2020, which has greatly slowdown the growth of the global economy, including the PRC, and this effect might be continued until the COVID 2019 was controlled by the human being. The slowdown of the growth of the PRC’s economy might has adversely effect on our current business and future developments if we would not catch the opportunities of the increasing demand of medical from the popular residents. The Company’s operations in the PRC are subject to special considerations. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company’s results may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation.

</us-gaap:ConcentrationRiskDisclosureTextBlock>

<TANAF:CashOnHandAndDepositsPercentage contextRef="AsOf2023-12-31" decimals="INF" id="Fact000773" unitRef="Pure"> 1 </TANAF:CashOnHandAndDepositsPercentage>

<TANAF:CashOnHandAndDepositsPercentage contextRef="AsOf2022-12-31" decimals="INF" id="Fact000775" unitRef="Pure"> 1 </TANAF:CashOnHandAndDepositsPercentage>

<us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000777">

SCHEDULE OF CONCENTRATION OF RISK <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Customers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zS52U06TdjKj" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUDnKOnz1ty4" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Customers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerAMember_zKUcvj90jxw7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerBMember_zHVn42dvpcLj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerCMember_ztbsrjIDLjg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr> <tr id="xdx_404_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerDMember_zptkZmidm2jj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerEMember_zgpvvtUTzQxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--CustomerFMember_zmiQsLU6ZHDi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table> The suppliers accounted for 10% or more of the Company’s purchases during the years ended December 31, 2023 and 2022. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Suppliers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjSgmMLUMxT6" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFDuzcngqDsi" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Suppliers</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--SuppliersAAMember_z7B2fiQLvf0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">AA</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">14</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">61</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--SuppliersBBMember_z6wVyC6vx5mg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">BB</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hsrt--MajorCustomersAxis__custom--SuppliersBBMember_zTOEexIEozqd" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Concentration risk percentage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr> </table>

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember" decimals="INF" id="Fact000780" unitRef="Pure"> 0.21 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember" decimals="INF" id="Fact000782" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember" decimals="INF" id="Fact000783" unitRef="Pure"> 0.17 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember" decimals="INF" id="Fact000785" unitRef="Pure"> 0.64 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember" decimals="INF" id="Fact000786" unitRef="Pure"> 0.15 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerDMember" decimals="INF" id="Fact000789" unitRef="Pure"> 0.10 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerEMember" decimals="INF" id="Fact000792" unitRef="Pure"> 0.10 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFMember" decimals="INF" id="Fact000794" unitRef="Pure"> 0.23 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_SuppliersAAMember" decimals="INF" id="Fact000797" unitRef="Pure"> 0.14 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_SuppliersAAMember" decimals="INF" id="Fact000798" unitRef="Pure"> 0.61 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_SuppliersBBMember" decimals="INF" id="Fact000800" unitRef="Pure"> 0.86 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_SuppliersBBMember" decimals="INF" id="Fact000801" unitRef="Pure"> 0.39 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_SuppliersBBMember" decimals="INF" id="Fact000803" unitRef="Pure"> 0.86 </us-gaap:ConcentrationRiskPercentage1>

<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_SuppliersBBMember" decimals="INF" id="Fact000804" unitRef="Pure"> 0.39 </us-gaap:ConcentrationRiskPercentage1>

</xbrl>

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/07/23  Tian’an Technology Group Ltd.     20-F       12/31/22   76:17M                                    M2 Compliance LLC/FA
 3/17/23  Tian’an Technology Group Ltd.     F-1/A                 19:25M                                    M2 Compliance LLC/FA

↑Top

Filing Submission 0001493152-24-012556 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Tian’an Technology Group Ltd. – ‘20-F’ for 12/31/23 – ‘XML’

On: Monday, 4/1/24, at 6:16pm ET · As of: 4/2/24 · For: 12/31/23 · Accession #: 1493152-24-12556 · File #: 333-267453

Previous ‘20-F’: ‘20-F’ on 6/7/23 for 12/31/22 · Latest ‘20-F’: This Filing · 2 References: To: Tian’an Technology Group Ltd. – Previous ‘20-F’ on 6/7/23 for 12/31/22 To: Tian’an Technology Group Ltd. – ‘F-1/A’ on 3/17/23

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer — Form 20-F — SEA’34Filing Table of Contents

‘XML’ — XBRL Instance — form20-f_htm

This Document is an XBRL File.

2 Previous Filings that this Filing References

Previous ‘20-F’: ‘20-F’ on 6/7/23 for 12/31/22 · Latest ‘20-F’: This Filing · 2 References:

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer — Form 20-F — SEA’34

Filing Table of Contents